<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31205079</PMID><DateCompleted><Year>2020</Year><Month>03</Month><Day>30</Day></DateCompleted><DateRevised><Year>2020</Year><Month>07</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1530-0293</ISSN><JournalIssue CitedMedium="Internet"><Volume>47</Volume><Issue>7</Issue><PubDate><Year>2019</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Critical care medicine</Title><ISOAbbreviation>Crit Care Med</ISOAbbreviation></Journal><ArticleTitle>Association of Blood Component Ratios With 24-Hour Mortality in Injured Children Receiving Massive Transfusion.</ArticleTitle><Pagination><StartPage>975</StartPage><EndPage>983</EndPage><MedlinePgn>975-983</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/CCM.0000000000003708</ELocationID><Abstract><AbstractText Label="OBJECTIVES">To determine if higher fresh frozen plasma and platelet to packed RBC ratios are associated with lower 24-hour mortality in bleeding pediatric trauma patients.</AbstractText><AbstractText Label="DESIGN">Retrospective cohort study using the Pediatric Trauma Quality Improvement Program Database from 2014 to 2016.</AbstractText><AbstractText Label="SETTING">Level I and II pediatric trauma centers participating in the Trauma Quality Improvement Program PATIENTS:: Injured children (&#x2264; 14 yr old) who received massive transfusion (&#x2265; 40&#x2009;mL/kg total blood products in 24&#x2009;hr). Of 123,836 patients, 590 underwent massive transfusion, of which 583 met inclusion criteria.</AbstractText><AbstractText Label="INTERVENTIONS">None.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS">Ratios of fresh frozen plasma:packed RBC and platelet:packed RBC. Of the 583 patients, 60% were male and the median age was 5 years (interquartile range, 2-10 yr). Overall mortality was 19.7% (95% CI, 16.6-23.2%) at 24 hours. There was 51% (adjusted relative risk, 0.49; 95% CI, 0.27-0.87; p = 0.02) and 40% (adjusted relative risk, 0.60; 95% CI, 0.39-0.92; p = 0.02) lower risk of death at 24 hours for the high (&#x2265; 1:1) and medium (&#x2265; 1:2 and &lt; 1:1) fresh frozen plasma:packed RBC ratio groups, respectively, compared with the low ratio group (&lt; 1:2). Platelet:packed RBC ratio was not associated with mortality (adjusted relative risk, 0.94; 95% CI, 0.51-1.71; p = 0.83).</AbstractText><AbstractText Label="CONCLUSIONS">Higher fresh frozen plasma ratios were associated with lower 24-hour mortality in massively transfused pediatric trauma patients. The platelet ratio was not associated with mortality. Although these findings represent the largest study evaluating blood product ratios in pediatric trauma patients, prospective studies are necessary to determine the optimum blood product ratios to minimize mortality in this population.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Butler</LastName><ForeName>Elissa K</ForeName><Initials>EK</Initials><AffiliationInfo><Affiliation>Harborview Injury Prevention and Research Center, University of Washington, Seattle, WA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, University of Washington, Seattle, WA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, SUNY Upstate Medical University, Syracuse, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mills</LastName><ForeName>Brianna M</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>Harborview Injury Prevention and Research Center, University of Washington, Seattle, WA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arbabi</LastName><ForeName>Saman</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Harborview Injury Prevention and Research Center, University of Washington, Seattle, WA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, University of Washington, Seattle, WA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bulger</LastName><ForeName>Eileen M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Harborview Injury Prevention and Research Center, University of Washington, Seattle, WA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, University of Washington, Seattle, WA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vavilala</LastName><ForeName>Monica S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Harborview Injury Prevention and Research Center, University of Washington, Seattle, WA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology &amp; Pain Medicine, University of Washington, Seattle, WA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Groner</LastName><ForeName>Jonathan I</ForeName><Initials>JI</Initials><AffiliationInfo><Affiliation>Center for Pediatric Trauma Research, Nationwide Children's Hospital, Columbus, OH.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatric Surgery, Nationwide Children's Hospital, Columbus, OH.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stansbury</LastName><ForeName>Lynn G</ForeName><Initials>LG</Initials><AffiliationInfo><Affiliation>Harborview Injury Prevention and Research Center, University of Washington, Seattle, WA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shock Trauma and Anesthesia Research Center, University of Maryland, Baltimore, MD.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hess</LastName><ForeName>John R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, University of Washington, Seattle, WA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rivara</LastName><ForeName>Frederick P</ForeName><Initials>FP</Initials><AffiliationInfo><Affiliation>Harborview Injury Prevention and Research Center, University of Washington, Seattle, WA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, University of Washington, Seattle, WA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>T32 HD057822</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Crit Care Med</MedlineTA><NlmUniqueID>0355501</NlmUniqueID><ISSNLinking>0090-3493</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016913" MajorTopicYN="N">Blood Component Transfusion</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017707" MajorTopicYN="N">Erythrocyte Transfusion</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006470" MajorTopicYN="N">Hemorrhage</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010949" MajorTopicYN="N">Plasma</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017713" MajorTopicYN="N">Platelet Transfusion</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014193" MajorTopicYN="N">Trauma Centers</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014947" MajorTopicYN="N">Wounds and Injuries</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Conflicts of interest: The authors have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>6</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>6</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>3</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>7</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31205079</ArticleId><ArticleId IdType="mid">NIHMS1520868</ArticleId><ArticleId IdType="pmc">PMC6581209</ArticleId><ArticleId IdType="doi">10.1097/CCM.0000000000003708</ArticleId><ArticleId IdType="pii">00003246-201907000-00012</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gilley M, Beno S. Damage control resuscitation in pediatric trauma. Curr Opin Pediatr 2018;30(3):338&#x2013;343.</Citation><ArticleIdList><ArticleId IdType="pubmed">29474273</ArticleId></ArticleIdList></Reference><Reference><Citation>Oyeniyi BT, Fox EE, Scerbo M, et al. Trends in 1029 trauma deaths at a level 1 trauma center: Impact of a bleeding control bundle of care. Injury 2017;48(1):5&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5193008</ArticleId><ArticleId IdType="pubmed">27847192</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendrickson JE, Shaz BH, Pereira G, et al. Implementation of a pediatric trauma massive transfusion protocol: one institution&#x2019;s experience. Transfusion 2012;52(6):1228&#x2013;1236.</Citation><ArticleIdList><ArticleId IdType="pubmed">22128884</ArticleId></ArticleIdList></Reference><Reference><Citation>Holcomb JB, Jenkins D, Rhee P, et al. Damage control resuscitation: directly addressing the early coagulopathy of trauma. J Trauma 2007;62(2):307&#x2013;310.</Citation><ArticleIdList><ArticleId IdType="pubmed">17297317</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran A, Campbell BT. The art and science of pediatric damage control. Semin Pediatr Surg 2017;26(1):21&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">28302281</ArticleId></ArticleIdList></Reference><Reference><Citation>Karam O, Tucci M. Massive Transfusion in Children. Transfus Med Rev 2016;30(4):213&#x2013;216.</Citation><ArticleIdList><ArticleId IdType="pubmed">27287298</ArticleId></ArticleIdList></Reference><Reference><Citation>Skelton T, Beno S. Massive transfusion in pediatric trauma: We need to focus more on &#x201c;how&#x201d;. J Trauma Acute Care Surg 2017;82(1):211&#x2013;215.</Citation><ArticleIdList><ArticleId IdType="pubmed">27779586</ArticleId></ArticleIdList></Reference><Reference><Citation>Clebone A Pediatric trauma transfusion and cognitive aids. Curr Opin Anaesthesiol 2018;31(2):201&#x2013;206.</Citation><ArticleIdList><ArticleId IdType="pubmed">29493552</ArticleId></ArticleIdList></Reference><Reference><Citation>Borgman MA, Spinella PC, Perkins JG, et al. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma 2007;63(4):805&#x2013;813.</Citation><ArticleIdList><ArticleId IdType="pubmed">18090009</ArticleId></ArticleIdList></Reference><Reference><Citation>Holcomb JB, del Junco DJ, Fox EE, et al. The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study: comparative effectiveness of a time-varying treatment with competing risks. JAMA Surg 2013;148(2):127&#x2013;136.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3740072</ArticleId><ArticleId IdType="pubmed">23560283</ArticleId></ArticleIdList></Reference><Reference><Citation>Holcomb JB, Tilley BC, Baraniuk S, et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA 2015;313(5):471&#x2013;482.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4374744</ArticleId><ArticleId IdType="pubmed">25647203</ArticleId></ArticleIdList></Reference><Reference><Citation>Cannon JW, Johnson MA, Caskey RC, et al. High ratio plasma resuscitation does not improve survival in pediatric trauma patients. J Trauma Acute Care Surg 2017;83(2):211&#x2013;217.</Citation><ArticleIdList><ArticleId IdType="pubmed">28481839</ArticleId></ArticleIdList></Reference><Reference><Citation>Edwards MJ, Lustik MB, Clark ME, et al. The effects of balanced blood component resuscitation and crystalloid administration in pediatric trauma patients requiring transfusion in Afghanistan and Iraq 2002 to 2012. J Trauma Acute Care Surg 2015;78(2):330&#x2013;335.</Citation><ArticleIdList><ArticleId IdType="pubmed">25757119</ArticleId></ArticleIdList></Reference><Reference><Citation>Nosanov L, Inaba K, Okoye O, et al. The impact of blood product ratios in massively transfused pediatric trauma patients. Am J Surg 2013;206(5):655&#x2013;660.</Citation><ArticleIdList><ArticleId IdType="pubmed">24011571</ArticleId></ArticleIdList></Reference><Reference><Citation>Karam O, Russell RT, Stricker P, et al. Recommendations on RBC Transfusion in Critically Ill Children With Nonlife-Threatening Bleeding or Hemorrhagic Shock From the Pediatric Critical Care Transfusion and Anemia Expertise Initiative. Pediatr Crit Care Med 2018;19(9S Suppl 1):S127&#x2013;S132.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6121734</ArticleId><ArticleId IdType="pubmed">30161067</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwu RS, Spinella PC, Keller MS, et al. The effect of massive transfusion protocol implementation on pediatric trauma care. Transfusion 2016;56(11):2712&#x2013;2719.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8345320</ArticleId><ArticleId IdType="pubmed">27572499</ArticleId></ArticleIdList></Reference><Reference><Citation>Neff LP, Cannon JW, Morrison JJ, et al. Clearly defining pediatric massive transfusion: cutting through the fog and friction with combat data. J Trauma Acute Care Surg 2015;78(1):22&#x2013;28;</Citation><ArticleIdList><ArticleId IdType="pubmed">25539199</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox EE, Holcomb JB, Wade CE, et al. Earlier Endpoints are Required for Hemorrhagic Shock Trials Among Severely Injured Patients. Shock 2017;47(5):567&#x2013;573.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5392160</ArticleId><ArticleId IdType="pubmed">28207628</ArticleId></ArticleIdList></Reference><Reference><Citation>ACS TQIP Massive Transfusion in Trauma Guidelines. [cited 2018 Aug 31]Available from: https://www.facs.org/~/media/files/quality%20programs/trauma/tqip/massive%20transfusion%20in%20trauma%20guildelines.ashx</Citation></Reference><Reference><Citation>Potoka DA, Schall LC, Ford HR. Development of a novel age-specific pediatric trauma score. J Pediatr Surg 2001;36(1):106&#x2013;112.</Citation><ArticleIdList><ArticleId IdType="pubmed">11150447</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings P Missing data and multiple imputation. JAMA Pediatr 2013;167(7):656&#x2013;661.</Citation><ArticleIdList><ArticleId IdType="pubmed">23699969</ArticleId></ArticleIdList></Reference><Reference><Citation>Haider AH, Hashmi ZG, Zafar SN, et al. Developing best practices to study trauma outcomes in large databases: an evidence-based approach to determine the best mortality risk adjustment model. J Trauma Acute Care Surg 2014;76(4):1061&#x2013;1069.</Citation><ArticleIdList><ArticleId IdType="pubmed">24662872</ArticleId></ArticleIdList></Reference><Reference><Citation>Givergis R, Munnangi S, Fayaz M Fomani K, et al. Evaluation of massive transfusion protocol practices by type of trauma at a level I trauma center. Chin J Traumatol 2018;21(5):261&#x2013;266.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6235793</ArticleId><ArticleId IdType="pubmed">29776837</ArticleId></ArticleIdList></Reference><Reference><Citation>Markov NP, DuBose JJ, Scott D, et al. Anatomic distribution and mortality of arterial injury in the wars in Afghanistan and Iraq with comparison to a civilian benchmark. J Vasc Surg 2012;56(3):728&#x2013;736.</Citation><ArticleIdList><ArticleId IdType="pubmed">22795520</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen CJ, Murray CR, Meizoso JP, et al. Risk factors for venous thromboembolism after pediatric trauma. J Pediatr Surg 2016;51(1):168&#x2013;171.</Citation><ArticleIdList><ArticleId IdType="pubmed">26547285</ArticleId></ArticleIdList></Reference><Reference><Citation>Snyder CW, Weinberg JA, McGwin G, et al. The relationship of blood product ratio to mortality: survival benefit or survival bias? J Trauma 2009;66(2):358&#x2013;362; discussion 362-354.</Citation><ArticleIdList><ArticleId IdType="pubmed">19204508</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">33000082</PMID><DateRevised><Year>2024</Year><Month>03</Month><Day>30</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2688-1152</ISSN><JournalIssue CitedMedium="Internet"><Volume>1</Volume><Issue>4</Issue><PubDate><Year>2020</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of the American College of Emergency Physicians open</Title><ISOAbbreviation>J Am Coll Emerg Physicians Open</ISOAbbreviation></Journal><ArticleTitle>Whole blood transfusion versus component therapy in trauma resuscitation: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>633</StartPage><EndPage>641</EndPage><MedlinePgn>633-641</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/emp2.12089</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Patients with hemorrhagic shock from trauma often require balanced blood product transfusion with red blood cells, plasma, and platelets. Resuscitation with whole blood resuscitation is becoming a common practice. We performed a systematic review and meta-analysis of studies comparing whole blood transfusion with balanced component therapy in patients suffering from traumatic hemorrhagic shock.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We searched MEDLINE Ovid, EMBASE, and the Cochrane Library for human studies comparing whole blood with component blood therapy published from January 2007 to June 2019. We included studies from both civilian and military settings and that reported 24-hour, in-hospital, or 30-day mortality. We followed the Preferred Reporting Items in Systematic Reviews and Meta-Analyses (PRISMA) guidelines, assessing study quality, publication bias, and heterogeneity. We used meta-analytic models to determine the associations (odds ratio [OR] with 95% confidence interval [CI]) between whole blood transfusion and (1) 24-hour mortality, and (2) in-hospital or 30-day mortality.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 1759 identified studies, 12 (reporting on n&#xa0;=&#xa0;8431 patients) met inclusion criteria. There was heterogeneity in the design, setting, interventions, and outcomes of the studies. On meta-analysis, whole blood transfusion was not associated with 24-hour mortality (OR&#xa0;=&#xa0;0.83; 95% CI&#xa0;=&#xa0;0.56-1.24) or in-hospital/30-day mortality (OR&#xa0;=&#xa0;0.79; 95% CI&#xa0;=&#xa0;0.48-1.31).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In this systematic review and meta-analysis, compared with conventional component transfusion, whole blood was not associated with 24-hour or in-hospital mortality. However, there were important limitations with and heterogeneity among the primary studies. Additional study is needed to determine the effectiveness of whole blood.</AbstractText><CopyrightInformation>&#xa9; 2020 The Authors. JACEP Open published by Wiley Periodicals LLC on behalf of the American College of Emergency Physicians.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Crowe</LastName><ForeName>Ellen</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>McGovern Medical School The University of Texas Health Science Center at Houston Houston Texas USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DeSantis</LastName><ForeName>Stacia M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Biostatistics and Data Science The University of Texas Health Science Center at Houston Houston Texas USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonnette</LastName><ForeName>Austin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine The University of Texas Health Science Center at Houston Houston Texas USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jansen</LastName><ForeName>Jan O</ForeName><Initials>JO</Initials><AffiliationInfo><Affiliation>Department of Surgery University of Alabama at Birmingham Birmingham Alabama USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamal</LastName><ForeName>Jose-Miguel</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Biostatistics and Data Science The University of Texas Health Science Center at Houston Houston Texas USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holcomb</LastName><ForeName>John B</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Department of Surgery University of Alabama at Birmingham Birmingham Alabama USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pedroza</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Pediatrics The University of Texas Health Science Center at Houston Houston Texas USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harvin</LastName><ForeName>John A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Surgery The University of Texas Health Science Center at Houston Houston Texas USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marques</LastName><ForeName>Marisa B</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>Department of Pathology University of Alabama at Birmingham Birmingham Alabama USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Avritscher</LastName><ForeName>Elenir B C</ForeName><Initials>EBC</Initials><AffiliationInfo><Affiliation>Department of Pediatrics The University of Texas Health Science Center at Houston Houston Texas USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Henry E</ForeName><Initials>HE</Initials><Identifier Source="ORCID">0000-0002-4738-0093</Identifier><AffiliationInfo><Affiliation>Department of Emergency Medicine The University of Texas Health Science Center at Houston Houston Texas USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U34 HL148472</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Am Coll Emerg Physicians Open</MedlineTA><NlmUniqueID>101764779</NlmUniqueID><ISSNLinking>2688-1152</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">blood products</Keyword><Keyword MajorTopicYN="N">hemorrhage</Keyword><Keyword MajorTopicYN="N">meta&#x2010;analysis</Keyword><Keyword MajorTopicYN="N">systematic review</Keyword><Keyword MajorTopicYN="N">transfusion</Keyword></KeywordList><CoiStatement>Dr. Michael Blaivas was the supervising editor for the final review process of this paper. Dr. Wang did not participate in the review process or editorial decision to publish the paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>3</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>4</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>4</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>1</Day><Hour>5</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>10</Month><Day>2</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>5</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33000082</ArticleId><ArticleId IdType="pmc">PMC7493478</ArticleId><ArticleId IdType="doi">10.1002/emp2.12089</ArticleId><ArticleId IdType="pii">EMP212089</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
Centers for Disease Control and Prevention. Injury Prevention &amp; Control. Web&#x2010;based Injury Statistics Query and Reporting System (WISQARS). Fatal Injury Data. Fatal Injury Reports, National, Regional and State, 1981&#x2010;2018. Available at https://webappa.cdc.gov/sasweb/ncipc/mortrate.html. Accessed May 15, 2020.</Citation></Reference><Reference><Citation>Holcomb JB, Tilley BC, Baraniuk S, et&#xa0;al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the proppr randomized clinical trialtransfusion in patients with severe traumatransfusion in patients with severe trauma. JAMA. 2015;313:471&#x2010;482.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4374744</ArticleId><ArticleId IdType="pubmed">25647203</ArticleId></ArticleIdList></Reference><Reference><Citation>Excellence NIfHa . Major Trauma: Assessment and Initial Management. Managing Haemorrhage in Pre&#x2010;hospital and Hospital Settings. Vol NICE Guideline, No. 39. London: National Institute for Healthcare and Excellence; 2016.</Citation><ArticleIdList><ArticleId IdType="pubmed">26913320</ArticleId></ArticleIdList></Reference><Reference><Citation>Cannon JW, Khan MA, Raja AS, et&#xa0;al. Damage control resuscitation in patients with severe traumatic hemorrhage: a practice management guideline from the Eastern Association for the Surgery of Trauma. J Trauma Acute Care Surg. 2017;82(3):605&#x2010;617.</Citation><ArticleIdList><ArticleId IdType="pubmed">28225743</ArticleId></ArticleIdList></Reference><Reference><Citation>Kauvar DS, Lefering R, Wade CE. Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations. J Trauma. 2006;60:S3&#x2010;S11.</Citation><ArticleIdList><ArticleId IdType="pubmed">16763478</ArticleId></ArticleIdList></Reference><Reference><Citation>Black JA, Pierce VS, Kerby JD, Holcomb JB. The evolution of blood transfusion in the trauma patient: whole blood has come full circle. Semin Thromb Hemost. 2020;46(2):215&#x2010;220.</Citation><ArticleIdList><ArticleId IdType="pubmed">31887756</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinella PC. Warm fresh whole blood transfusion for severe hemorrhage: u.S. military and potential civilian applications. Crit Care Med. 2008;36:S340&#x2010;S345.</Citation><ArticleIdList><ArticleId IdType="pubmed">18594261</ArticleId></ArticleIdList></Reference><Reference><Citation>Cotton BA, Podbielski J, Camp E, et&#xa0;al. A randomized controlled pilot trial of modified whole blood versus component therapy in severely injured patients requiring large volume transfusions. Ann Surg. 2013;258:527&#x2010;532.</Citation><ArticleIdList><ArticleId IdType="pubmed">23979267</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG, Group P . Preferred reporting items for systematic reviews and meta&#x2010;analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097&#x2010;e1000097.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2707599</ArticleId><ArticleId IdType="pubmed">19621072</ArticleId></ArticleIdList></Reference><Reference><Citation>Schardt C, Adams MB, Owens T, Keitz S, Fontelo P. Utilization of the PICO framework to improve searching PubMed for clinical questions. BMC Med Inf Decis Making. 2007;7:16&#x2010;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1904193</ArticleId><ArticleId IdType="pubmed">17573961</ArticleId></ArticleIdList></Reference><Reference><Citation>Hess JR, Holcomb JB, Hoyt DB. Damage control resuscitation: the need for specific blood products to treat the coagulopathy of trauma. Transfusion. 2006;46:685&#x2010;686.</Citation><ArticleIdList><ArticleId IdType="pubmed">16686833</ArticleId></ArticleIdList></Reference><Reference><Citation>Holcomb JB, Jenkins D, Rhee P, et&#xa0;al. Damage control resuscitation: directly addressing the early coagulopathy of trauma. J Trauma. 2007;62:307&#x2010;310.</Citation><ArticleIdList><ArticleId IdType="pubmed">17297317</ArticleId></ArticleIdList></Reference><Reference><Citation>Cotton BA, Reddy N, Hatch QM, et&#xa0;al. Damage control resuscitation is associated with a reduction in resuscitation volumes and improvement in survival in 390 damage control laparotomy patients. Ann Surg. 2011;254:598&#x2010;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3816774</ArticleId><ArticleId IdType="pubmed">21918426</ArticleId></ArticleIdList></Reference><Reference><Citation>Stang A. Critical evaluation of the Newcastle&#x2010;Ottawa scale for the assessment of the quality of nonrandomized studies in meta&#x2010;analyses. Eur J Epidemiol. 2010;25:603&#x2010;605.</Citation><ArticleIdList><ArticleId IdType="pubmed">20652370</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox EE, Holcomb JB, Wade CE, Bulger EM, Tilley BC, Group PS . Earlier endpoints are required for hemorrhagic shock trials among severely injured patients. Shock. 2017;47:567&#x2010;573.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5392160</ArticleId><ArticleId IdType="pubmed">28207628</ArticleId></ArticleIdList></Reference><Reference><Citation>Harbord RM, Egger M, Sterne JA. A modified test for small&#x2010;study effects in meta&#x2010;analyses of controlled trials with binary endpoints. Stat Med. 2006;25:3443&#x2010;3457.</Citation><ArticleIdList><ArticleId IdType="pubmed">16345038</ArticleId></ArticleIdList></Reference><Reference><Citation>DerSimonian R, Laird N. Meta&#x2010;analysis in clinical trials. Control Clin Trials. 1986;7:177&#x2010;188.</Citation><ArticleIdList><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>Seheult JN, Anto V, Alarcon LH, Sperry JL, Triulzi DJ, Yazer MH. Clinical outcomes among low&#x2010;titer group O whole blood recipients compared to recipients of conventional components in civilian trauma resuscitation. Transfusion. 2018;58:1838&#x2010;1845.</Citation><ArticleIdList><ArticleId IdType="pubmed">30160310</ArticleId></ArticleIdList></Reference><Reference><Citation>Yazer MH, Jackson B, Sperry JL, Alarcon L, Triulzi DJ, Murdock AD. Initial safety and feasibility of cold&#x2010;stored uncrossmatched whole blood transfusion in civilian trauma patients. J Trauma Acute Care Surg. 2016;81:21&#x2010;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">27120323</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu CS, Pokorny DM, Eastridge BJ, et&#xa0;al. Give the trauma patient what they bleed, when and where they need it: establishing a comprehensive regional system of resuscitation based on patient need utilizing cold&#x2010;stored, low&#x2010;titer O+ whole blood. Transfusion. 2019;59:1429&#x2010;1438.</Citation><ArticleIdList><ArticleId IdType="pubmed">30980748</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams J, Merutka N, Meyer D, et&#xa0;al. Safety Profile and Impact of Low&#x2010;Titer Group O Whole Blood for Emergency Use in Trauma. J Trauma Acute Care Surg. 2020;88(1):87&#x2010;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">31464874</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho KM, Leonard AD. Lack of effect of unrefrigerated young whole blood transfusion on patient outcomes after massive transfusion in a civilian setting. Transfusion. 2011;51:1669&#x2010;1675.</Citation><ArticleIdList><ArticleId IdType="pubmed">21175645</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones AR, Frazier SK. Increased mortality in adult patients with trauma transfused with blood components compared with whole blood. J Trauma Nurs. 2014;21:22&#x2010;29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4126240</ArticleId><ArticleId IdType="pubmed">24399315</ArticleId></ArticleIdList></Reference><Reference><Citation>Auten JD, Lunceford NL, Horton JL, et&#xa0;al. The safety of early fresh, whole blood transfusion among severely battle injured at US Marine Corps forward surgical care facilities in Afghanistan. J Trauma Acute Care Surg. 2015;79:790&#x2010;796.</Citation><ArticleIdList><ArticleId IdType="pubmed">26496103</ArticleId></ArticleIdList></Reference><Reference><Citation>Keneally RJ, Parsons AM, Willett PB. Warm fresh whole blood and thoracic Traumain Iraq and Afghanistan. J Emerg Trauma Shock. 2015;8:21&#x2010;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4335151</ArticleId><ArticleId IdType="pubmed">25709248</ArticleId></ArticleIdList></Reference><Reference><Citation>Nessen SC, Eastridge BJ, Cronk D, et&#xa0;al. Fresh whole blood use by forward surgical teams in Afghanistan is associated with improved survival compared to component therapy without platelets. Transfusion. 2013;53(Suppl 1):107S&#x2010;113S.</Citation><ArticleIdList><ArticleId IdType="pubmed">23301962</ArticleId></ArticleIdList></Reference><Reference><Citation>Perkins JG, Cap AP, Spinella PC, et&#xa0;al. Comparison of platelet transfusion as fresh whole blood versus apheresis platelets for massively transfused combat trauma patients (CME). Transfusion. 2011;51:242&#x2010;252.</Citation><ArticleIdList><ArticleId IdType="pubmed">20796254</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinella PC, Perkins JG, Grathwohl KW, Beekley AC, Holcomb JB. Warm fresh whole blood is independently associated with improved survival for patients with combat&#x2010;related traumatic injuries. J Trauma. 2009;66:S69&#x2010;S76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3126655</ArticleId><ArticleId IdType="pubmed">19359973</ArticleId></ArticleIdList></Reference><Reference><Citation>Greene TJ, DeSantis SM, Fox EE, Wade CE, Holcomb JB, Swartz MD. Utilizing propensity score analyses in prehospital blood product transfusion studies: lessons learned and moving toward best practice. Mil Med. 2018;183:124&#x2010;133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6020820</ArticleId><ArticleId IdType="pubmed">29635550</ArticleId></ArticleIdList></Reference><Reference><Citation>DeSantis SM, Swartz MD, Greene TJ, Fox EE, Holcomb JB, Wade CE, PROHS Study Group . Interim monitoring of non&#x2010;randomized prospective studies that invoke propensity scoring for decision&#x2010;making. J Trauma Acute Care Surg. 2020;88(2):e46&#x2010;e52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7001616</ArticleId><ArticleId IdType="pubmed">31996656</ArticleId></ArticleIdList></Reference><Reference><Citation>Veigas PV, Callum J, Rizoli S, Nascimento B, da Luz LT. A systematic review on the rotational thrombelastometry (ROTEM&#xae;) values for the diagnosis of coagulopathy, prediction and guidance of blood transfusion and prediction of mortality in trauma patients. Scand J Trauma Resusc Emerg Med. 2016;24:114&#x2010;114.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5048662</ArticleId><ArticleId IdType="pubmed">27716278</ArticleId></ArticleIdList></Reference><Reference><Citation>Jansen JO, Pallmann P, MacLennan G, Campbell MK, Investigators U&#x2010;RT. Bayesian clinical trial designs: another option for trauma trials. J Trauma Acute Care Surg. 2017;83:736&#x2010;741.</Citation><ArticleIdList><ArticleId IdType="pubmed">28930965</ArticleId></ArticleIdList></Reference><Reference><Citation>Holcomb JB, Jenkins DH. Get ready: whole blood is back and it's good for patients. Transfusion. 2018;58:1821&#x2010;1823.</Citation><ArticleIdList><ArticleId IdType="pubmed">30144081</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36449300</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>13</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2168-6262</ISSN><JournalIssue CitedMedium="Internet"><Volume>158</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month><Day>01</Day></PubDate></JournalIssue><Title>JAMA surgery</Title><ISOAbbreviation>JAMA Surg</ISOAbbreviation></Journal><ArticleTitle>Association Between Hemorrhage Control Interventions and Mortality in US Trauma Patients With Hemodynamically Unstable Pelvic Fractures.</ArticleTitle><Pagination><StartPage>63</StartPage><EndPage>71</EndPage><MedlinePgn>63-71</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamasurg.2022.5772</ELocationID><Abstract><AbstractText Label="IMPORTANCE">Management of hemodynamically unstable pelvic fractures remains a challenge. Hemostatic interventions are used alone or in combination. There is a paucity of data on the association between the pattern of hemorrhage control interventions and outcomes after a severe pelvic fracture.</AbstractText><AbstractText Label="OBJECTIVE">To characterize clinical outcomes and study the patterns of hemorrhage control interventions in hemodynamically unstable pelvic fractures.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">In this cohort study, a retrospective review was performed of data from the 2017 American College of Surgeons Trauma Quality Improvement Program database, a national multi-institutional database of trauma patients in the United States. Adult patients (aged &#x2265;18 years) with pelvic fractures who received early transfusions (&#x2265;4 units of packed red blood cells in 4 hours) and underwent intervention for pelvic hemorrhage control were identified. Use and order of preperitoneal pelvic packing (PP), pelvic angioembolization (AE), and resuscitative endovascular balloon occlusion of the aorta (REBOA) in zone 3 were examined and compared against the primary outcome of mortality. The associations between intervention patterns and mortality, complications, and 24-hour transfusions were further examined by backward stepwise regression analyses. Data analyses were performed in September 2021.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES">Primary outcomes were rates of 24-hour, emergency department, and in-hospital mortality. Secondary outcomes were major in-hospital complications.</AbstractText><AbstractText Label="RESULTS">A total of 1396 patients were identified. Mean (SD) age was 47 (19) years, 975 (70%) were male, and the mean (SD) lowest systolic blood pressure was 71 (25) mm Hg. The median (IQR) Injury Severity Score was 24 (14-34), with a 24-hour mortality of 217 patients (15.5%), ED mortality of 10 patients (0.7%), in-hospital mortality of 501 patients (36%), and complication rate of 574 patients (41%). Pelvic AE was the most used intervention (774 [55%]), followed by preperitoneal PP (659 [47%]) and REBOA zone 3 (126 [9%]). Among the cohort, 1236 patients (89%) had 1 intervention, 157 (11%) had 2 interventions, and 3 (0.2%) had 3 interventions. On regression analyses, only pelvic AE was associated with a mortality reduction (odds ratio [OR], 0.62; 95% CI, 0.47 to 0.82; P&#x2009;&lt;&#x2009;.001). Preperitoneal PP was associated with increased odds of complications (OR, 1.39; 95% CI, 1.07 to 1.80; P&#x2009;=&#x2009;.01). Increasing number of interventions was associated with increased 24-hour transfusions (&#x3b2;&#x2009;=&#x2009;+5.4; 95% CI, +3.5 to +7.5; P&#x2009;&lt;&#x2009;.001) and mortality (OR, 1.57; 95% CI, 1.05 to 2.37; P&#x2009;=&#x2009;.03), but not with complications.</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE">This study found that among patients with pelvic fracture who received early transfusions and at least 1 invasive pelvic hemorrhage control intervention, more than 1 in 3 died, despite the availability of advanced hemorrhage control interventions. Only pelvic AE was associated with a reduction in mortality.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Anand</LastName><ForeName>Tanya</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>College of Medicine, Division of Trauma, Critical Care, Burns, and Emergency Surgery, Department of Surgery, University of Arizona, Tucson.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El-Qawaqzeh</LastName><ForeName>Khaled</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>College of Medicine, Division of Trauma, Critical Care, Burns, and Emergency Surgery, Department of Surgery, University of Arizona, Tucson.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nelson</LastName><ForeName>Adam</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>College of Medicine, Division of Trauma, Critical Care, Burns, and Emergency Surgery, Department of Surgery, University of Arizona, Tucson.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hosseinpour</LastName><ForeName>Hamidreza</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>College of Medicine, Division of Trauma, Critical Care, Burns, and Emergency Surgery, Department of Surgery, University of Arizona, Tucson.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ditillo</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>College of Medicine, Division of Trauma, Critical Care, Burns, and Emergency Surgery, Department of Surgery, University of Arizona, Tucson.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gries</LastName><ForeName>Lynn</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>College of Medicine, Division of Trauma, Critical Care, Burns, and Emergency Surgery, Department of Surgery, University of Arizona, Tucson.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castanon</LastName><ForeName>Lourdes</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>College of Medicine, Division of Trauma, Critical Care, Burns, and Emergency Surgery, Department of Surgery, University of Arizona, Tucson.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joseph</LastName><ForeName>Bellal</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>College of Medicine, Division of Trauma, Critical Care, Burns, and Emergency Surgery, Department of Surgery, University of Arizona, Tucson.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Surg</MedlineTA><NlmUniqueID>101589553</NlmUniqueID><ISSNLinking>2168-6254</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>JAMA Surg. 2023 Jan 1;158(1):71-72. doi: 10.1001/jamasurg.2022.5778.</RefSource><PMID Version="1">36449322</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006470" MajorTopicYN="N">Hemorrhage</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050723" MajorTopicYN="Y">Fractures, Bone</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010384" MajorTopicYN="Y">Pelvic Bones</DescriptorName><QualifierName UI="Q000293" MajorTopicYN="N">injuries</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D021721" MajorTopicYN="Y">Balloon Occlusion</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015601" MajorTopicYN="N">Injury Severity Score</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> None reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>30</Day><Hour>11</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36449300</ArticleId><ArticleId IdType="pmc">PMC9713682</ArticleId><ArticleId IdType="doi">10.1001/jamasurg.2022.5772</ArticleId><ArticleId IdType="pii">2799004</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rhee P, Joseph B, Pandit V, et al. . Increasing trauma deaths in the United States. Ann Surg. 2014;260(1):13-21. doi:10.1097/SLA.0000000000000600</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000000600</ArticleId><ArticleId IdType="pubmed">24651132</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker CC, Oppenheimer L, Stephens B, Lewis FR, Trunkey DD. Epidemiology of trauma deaths. Am J Surg. 1980;140(1):144-150. doi:10.1016/0002-9610(80)90431-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9610(80)90431-6</ArticleId><ArticleId IdType="pubmed">7396078</ArticleId></ArticleIdList></Reference><Reference><Citation>Sauaia A, Moore FA, Moore EE, et al. . Epidemiology of trauma deaths: a reassessment. J Trauma. 1995;38(2):185-193. doi:10.1097/00005373-199502000-00006</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005373-199502000-00006</ArticleId><ArticleId IdType="pubmed">7869433</ArticleId></ArticleIdList></Reference><Reference><Citation>de Knegt C, Meylaerts SA, Leenen LP. Applicability of the trimodal distribution of trauma deaths in a Level I trauma centre in the Netherlands with a population of mainly blunt trauma. Injury. 2008;39(9):993-1000. doi:10.1016/j.injury.2008.03.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2008.03.033</ArticleId><ArticleId IdType="pubmed">18656867</ArticleId></ArticleIdList></Reference><Reference><Citation>Demetriades D, Karaiskakis M, Toutouzas K, Alo K, Velmahos G, Chan L. Pelvic fractures: epidemiology and predictors of associated abdominal injuries and outcomes. J Am Coll Surg. 2002;195(1):1-10. doi:10.1016/S1072-7515(02)01197-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1072-7515(02)01197-3</ArticleId><ArticleId IdType="pubmed">12113532</ArticleId></ArticleIdList></Reference><Reference><Citation>Costantini TW, Coimbra R, Holcomb JB, et al. ; AAST Pelvic Fracture Study Group . Current management of hemorrhage from severe pelvic fractures: results of an American Association for the Surgery of Trauma multi-institutional trial. J Trauma Acute Care Surg. 2016;80(5):717-723. doi:10.1097/TA.0000000000001034</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0000000000001034</ArticleId><ArticleId IdType="pubmed">26958799</ArticleId></ArticleIdList></Reference><Reference><Citation>Costantini TW, Coimbra R, Holcomb JB, et al. ; AAST Pelvic Fracture Study Group . Pelvic fracture pattern predicts the need for hemorrhage control intervention: results of an AAST multi-institutional study. J Trauma Acute Care Surg. 2017;82(6):1030-1038. doi:10.1097/TA.0000000000001465</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0000000000001465</ArticleId><ArticleId IdType="pubmed">28520685</ArticleId></ArticleIdList></Reference><Reference><Citation>Cannon JW. Hemorrhagic shock. N Engl J Med. 2018;378(4):370-379. doi:10.1056/NEJMra1705649</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1705649</ArticleId><ArticleId IdType="pubmed">29365303</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein DM, O&#x2019;Toole R, Scalea TM. Multidisciplinary approach for patients with pelvic fractures and hemodynamic instability. Scand J Surg. 2007;96(4):272-280. doi:10.1177/145749690709600403</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/145749690709600403</ArticleId><ArticleId IdType="pubmed">18265853</ArticleId></ArticleIdList></Reference><Reference><Citation>Cullinane DC, Schiller HJ, Zielinski MD, et al. . Eastern Association for the Surgery of Trauma practice management guidelines for hemorrhage in pelvic fracture: update and systematic review. J Trauma. 2011;71(6):1850-1868. doi:10.1097/TA.0b013e31823dca9a</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0b013e31823dca9a</ArticleId><ArticleId IdType="pubmed">22182895</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran TLN, Brasel KJ, Karmy-Jones R, et al. . Western Trauma Association critical decisions in trauma: management of pelvic fracture with hemodynamic instability, 2016 updates. J Trauma Acute Care Surg. 2016;81(6):1171-1174. doi:10.1097/TA.0000000000001230</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0000000000001230</ArticleId><ArticleId IdType="pubmed">27537512</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsushima K, Piccinini A, Schellenberg M, et al. . Effect of door-to-angioembolization time on mortality in pelvic fracture: every hour of delay counts. J Trauma Acute Care Surg. 2018;84(5):685-692. doi:10.1097/TA.0000000000001803</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0000000000001803</ArticleId><ArticleId IdType="pubmed">29370067</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz DA, Medina M, Cotton BA, et al. . Are we delivering two standards of care for pelvic trauma? availability of angioembolization after hours and on weekends increases time to therapeutic intervention. J Trauma Acute Care Surg. 2014;76(1):134-139. doi:10.1097/TA.0b013e3182ab0cfc</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0b013e3182ab0cfc</ArticleId><ArticleId IdType="pubmed">24368368</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshihara H, Yoneoka D. Demographic epidemiology of unstable pelvic fracture in the United States from 2000 to 2009: trends and in-hospital mortality. J Trauma Acute Care Surg. 2014;76(2):380-385. doi:10.1097/TA.0b013e3182ab0cde</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0b013e3182ab0cde</ArticleId><ArticleId IdType="pubmed">24398776</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothenberger DA, Fischer RP, Strate RG, Velasco R, Perry JF Jr. The mortality associated with pelvic fractures. Surgery. 1978;84(3):356-361.</Citation><ArticleIdList><ArticleId IdType="pubmed">684627</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong KH, DeCoster T, Osler T, Robinson B. Pelvic fractures and mortality. Iowa Orthop J. 1997;17:110-114.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2378101</ArticleId><ArticleId IdType="pubmed">9234982</ArticleId></ArticleIdList></Reference><Reference><Citation>Sathy AK, Starr AJ, Smith WR, et al. . The effect of pelvic fracture on mortality after trauma: an analysis of 63,000 trauma patients. J Bone Joint Surg Am. 2009;91(12):2803-2810. doi:10.2106/JBJS.H.00598</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.H.00598</ArticleId><ArticleId IdType="pubmed">19952241</ArticleId></ArticleIdList></Reference><Reference><Citation>Flint L, Babikian G, Anders M, Rodriguez J, Steinberg S. Definitive control of mortality from severe pelvic fracture. Ann Surg. 1990;211(6):703-706. doi:10.1097/00000658-199006000-00008</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000658-199006000-00008</ArticleId><ArticleId IdType="pmc">PMC1358117</ArticleId><ArticleId IdType="pubmed">2357133</ArticleId></ArticleIdList></Reference><Reference><Citation>Perkins ZB, Maytham GD, Koers L, Bates P, Brohi K, Tai NR. Impact on outcome of a targeted performance improvement programme in haemodynamically unstable patients with a pelvic fracture. Bone Joint J. 2014;96-B(8):1090-1097. doi:10.1302/0301-620X.96B8.33383</Citation><ArticleIdList><ArticleId IdType="doi">10.1302/0301-620X.96B8.33383</ArticleId><ArticleId IdType="pubmed">25086126</ArticleId></ArticleIdList></Reference><Reference><Citation>Cothren CC, Osborn PM, Moore EE, Morgan SJ, Johnson JL, Smith WR. Preperitonal pelvic packing for hemodynamically unstable pelvic fractures: a paradigm shift. J Trauma. 2007;62(4):834-839. doi:10.1097/TA.0b013e31803c7632</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0b013e31803c7632</ArticleId><ArticleId IdType="pubmed">17426537</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenner M, Moore L, Zakhary B, et al. . Scalpel or sheath? outcomes comparison between pre-peritoneal pelvic packing and angioembolization for definitive hemorrhage control after REBOA. Endovasc Resusc Trauma Manag. 2020;4(1). doi:10.26676/jevtm.v4i1.119</Citation><ArticleIdList><ArticleId IdType="doi">10.26676/jevtm.v4i1.119</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorson CM, Ryan ML, Otero CA, et al. . Operating room or angiography suite for hemodynamically unstable pelvic fractures? J Trauma Acute Care Surg. 2012;72(2):364-370. doi:10.1097/TA.0b013e318243da10</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0b013e318243da10</ArticleId><ArticleId IdType="pubmed">22327978</ArticleId></ArticleIdList></Reference><Reference><Citation>Asmar S, Bible L, Chehab M, Tang A, Khurrum M, Douglas M, et al. . Resuscitative endovascular balloon occlusion of the aorta vs pre-peritoneal packing in patients with pelvic fracture. J Am Coll Surg. 2021;232(1):17-26.e2. doi:10.1016/j.jamcollsurg.2020.08.763</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamcollsurg.2020.08.763</ArticleId><ArticleId IdType="pubmed">33022396</ArticleId></ArticleIdList></Reference><Reference><Citation>Mikdad S, van Erp IAM, Moheb ME, et al. . Pre-peritoneal pelvic packing for early hemorrhage control reduces mortality compared to resuscitative endovascular balloon occlusion of the aorta in severe blunt pelvic trauma patients: a nationwide analysis. Injury. 2020;51(8):1834-1839. doi:10.1016/j.injury.2020.06.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2020.06.003</ArticleId><ArticleId IdType="pubmed">32564964</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33595600</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>24</Day></DateCompleted><DateRevised><Year>2022</Year><Month>02</Month><Day>18</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2168-6262</ISSN><JournalIssue CitedMedium="Internet"><Volume>156</Volume><Issue>5</Issue><PubDate><Year>2021</Year><Month>May</Month><Day>01</Day></PubDate></JournalIssue><Title>JAMA surgery</Title><ISOAbbreviation>JAMA Surg</ISOAbbreviation></Journal><ArticleTitle>Association of Cryoprecipitate Use With Survival After Major Trauma in Children Receiving Massive Transfusion.</ArticleTitle><Pagination><StartPage>453</StartPage><EndPage>460</EndPage><MedlinePgn>453-460</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamasurg.2020.7199</ELocationID><Abstract><AbstractText Label="IMPORTANCE">Although most massive transfusion protocols incorporate cryoprecipitate in the treatment of hemorrhaging injured patients, minimal data exist on its use in children, and whether its addition improves their survival is unclear.</AbstractText><AbstractText Label="OBJECTIVE">To determine whether cryoprecipitate use for injured children who receive massive transfusion is associated with lower mortality.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">This retrospective cohort study included injured patients examined between January 1, 2014, and December 31, 2017, at one of multiple centers across the US and Canada participating in the Pediatric Trauma Quality Improvement Program. Patients were aged 18 years or younger and had received massive transfusion, which was defined as at least 40 mL/kg of total blood products in the first 4 hours after emergency department arrival. Exclusion criteria included hospital transfer, arrival without signs of life, time of death or hospital discharge not recorded, and isolated head injuries. To adjust for potential confounding, a propensity score for treatment was created and inverse probability weighting was applied. The propensity score accounted for age, sex, race/ethnicity, injury type, payment type, Glasgow Coma Scale score, hypoxia, hypotension, assisted respirations, chest tube status, Injury Severity Score, total volume of blood products received, hemorrhage control procedure, hospital size, academic status, and trauma center designation. Data were analyzed from December 11, 2019, to August 31, 2020.</AbstractText><AbstractText Label="EXPOSURES">Cryoprecipitate use within the first 4 hours of emergency department arrival.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES">In-hospital 24-hour and 7-day mortality.</AbstractText><AbstractText Label="RESULTS">Of the 2387 injured patients who received massive transfusion, 1948 patients were eligible for analysis. The median age was 16 years (interquartile range, 9-17 years), 1382 patients (70.9%) were male, and 807 (41.4%) were White. A total of 541 patients (27.8%) received cryoprecipitate. After propensity score weighting, patients who received cryoprecipitate had a significantly lower 24-hour mortality when compared with those who did not (adjusted difference, -6.9%; 95% CI, -10.6% to -3.2%). Moreover, cryoprecipitate use was associated with a significantly lower 7-day mortality but only in children with penetrating trauma (adjusted difference, -9.2%; 95% CI, -15.4% to -3.0%) and those transfused at least 100 mL/kg of total blood products (adjusted difference, -7.7%; 95% CI, -15.0% to -0.5%).</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE">In this cohort study, early use of cryoprecipitate was associated with lower 24-hour mortality among injured children who required massive transfusion. The benefit of cryoprecipitate appeared to persist for 7 days only in those with penetrating trauma and in those who received extremely large-volume transfusion.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tama</LastName><ForeName>Maria A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Division of Pediatrics, Department of Emergency Medicine, Staten Island University Hospital, Staten Island, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stone</LastName><ForeName>Melvin E</ForeName><Initials>ME</Initials><Suffix>Jr</Suffix><AffiliationInfo><Affiliation>Division of Trauma, Department of Surgery, Jacobi Medical Center, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blumberg</LastName><ForeName>Stephen M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Division of Emergency Medicine, Department of Pediatrics, Jacobi Medical Center, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reddy</LastName><ForeName>Srinivas H</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Division of Trauma, Department of Surgery, Jacobi Medical Center, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Conway</LastName><ForeName>Edward E</ForeName><Initials>EE</Initials><Suffix>Jr</Suffix><AffiliationInfo><Affiliation>Division of Critical Care, Department of Pediatrics, Jacobi Medical Center, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meltzer</LastName><ForeName>James A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Division of Emergency Medicine, Department of Pediatrics, Jacobi Medical Center, Bronx, New York.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Surg</MedlineTA><NlmUniqueID>101589553</NlmUniqueID><ISSNLinking>2168-6254</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C026912">cryoprecipitate coagulum</NameOfSubstance></Chemical><Chemical><RegistryNumber>9001-27-8</RegistryNumber><NameOfSubstance UI="D005169">Factor VIII</NameOfSubstance></Chemical><Chemical><RegistryNumber>9001-32-5</RegistryNumber><NameOfSubstance UI="D005340">Fibrinogen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>JAMA Surg. 2021 May 1;156(5):460-461. doi: 10.1001/jamasurg.2020.7266.</RefSource><PMID Version="1">33595623</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001803" MajorTopicYN="Y">Blood Transfusion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005169" MajorTopicYN="N">Factor VIII</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005340" MajorTopicYN="N">Fibrinogen</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006470" MajorTopicYN="N">Hemorrhage</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057216" MajorTopicYN="N">Propensity Score</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014949" MajorTopicYN="N">Wounds, Nonpenetrating</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014950" MajorTopicYN="N">Wounds, Penetrating</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> None reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>2</Month><Day>17</Day><Hour>12</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>2</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33595600</ArticleId><ArticleId IdType="pmc">PMC7890443</ArticleId><ArticleId IdType="doi">10.1001/jamasurg.2020.7199</ArticleId><ArticleId IdType="pii">2776433</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cunningham RM, Walton MA, Carter PM. The major causes of death in children and adolescents in the United States. N Engl J Med. 2018;379(25):2468-2475. doi:10.1056/NEJMsr1804754</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMsr1804754</ArticleId><ArticleId IdType="pmc">PMC6637963</ArticleId><ArticleId IdType="pubmed">30575483</ArticleId></ArticleIdList></Reference><Reference><Citation>Brysiewicz P, Clarke DL, Sartorius B, Bruce JL, Laing GL. Defining predictors of mortality in pediatric trauma patients. S Afr J Surg. 2017;55(3):36-40.</Citation><ArticleIdList><ArticleId IdType="pubmed">28876563</ArticleId></ArticleIdList></Reference><Reference><Citation>Cannon JW, Khan MA, Raja AS, et al. . Damage control resuscitation in patients with severe traumatic hemorrhage: a practice management guideline from the Eastern Association for the Surgery of Trauma. J Trauma Acute Care Surg. 2017;82(3):605-617. doi:10.1097/TA.0000000000001333</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0000000000001333</ArticleId><ArticleId IdType="pubmed">28225743</ArticleId></ArticleIdList></Reference><Reference><Citation>Patil V, Shetmahajan M. Massive transfusion and massive transfusion protocol. Indian J Anaesth. 2014;58(5):590-595. doi:10.4103/0019-5049.144662</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0019-5049.144662</ArticleId><ArticleId IdType="pmc">PMC4260305</ArticleId><ArticleId IdType="pubmed">25535421</ArticleId></ArticleIdList></Reference><Reference><Citation>Holcomb JB, del Junco DJ, Fox EE, et al. ; PROMMTT Study Group . The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study: comparative effectiveness of a time-varying treatment with competing risks. JAMA Surg. 2013;148(2):127-136. doi:10.1001/2013.jamasurg.387</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/2013.jamasurg.387</ArticleId><ArticleId IdType="pmc">PMC3740072</ArticleId><ArticleId IdType="pubmed">23560283</ArticleId></ArticleIdList></Reference><Reference><Citation>Holcomb JB, Tilley BC, Baraniuk S, et al. ; PROPPR Study Group . Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA. 2015;313(5):471-482. doi:10.1001/jama.2015.12</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2015.12</ArticleId><ArticleId IdType="pmc">PMC4374744</ArticleId><ArticleId IdType="pubmed">25647203</ArticleId></ArticleIdList></Reference><Reference><Citation>Maw G, Furyk C. Pediatric massive transfusion: a systematic review. Pediatr Emerg Care. 2018;34(8):594-598. doi:10.1097/PEC.0000000000001570</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PEC.0000000000001570</ArticleId><ArticleId IdType="pubmed">30080793</ArticleId></ArticleIdList></Reference><Reference><Citation>Nascimento B, Goodnough LT, Levy JH. Cryoprecipitate therapy. Br J Anaesth. 2014;113(6):922-934. doi:10.1093/bja/aeu158</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aeu158</ArticleId><ArticleId IdType="pmc">PMC4627369</ArticleId><ArticleId IdType="pubmed">24972790</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng N, Su L. Progresses in understanding trauma-induced coagulopathy and the underlying mechanism. Chin J Traumatol. 2017;20(3):133-136. doi:10.1016/j.cjtee.2017.03.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjtee.2017.03.002</ArticleId><ArticleId IdType="pmc">PMC5473738</ArticleId><ArticleId IdType="pubmed">28554592</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendrickson JE, Shaz BH, Pereira G, et al. . Coagulopathy is prevalent and associated with adverse outcomes in transfused pediatric trauma patients. J Pediatr. 2012;160(2):204-209.e3. doi:10.1016/j.jpeds.2011.08.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2011.08.019</ArticleId><ArticleId IdType="pubmed">21925679</ArticleId></ArticleIdList></Reference><Reference><Citation>Olaussen A, Fitzgerald MC, Tan GA, Mitra B. Cryoprecipitate administration after trauma. Eur J Emerg Med. 2016;23(4):269-273. doi:10.1097/MEJ.0000000000000259</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MEJ.0000000000000259</ArticleId><ArticleId IdType="pubmed">25734480</ArticleId></ArticleIdList></Reference><Reference><Citation>Bardes JM, Inaba K, Schellenberg M, et al. . The contemporary timing of trauma deaths. J Trauma Acute Care Surg. 2018;84(6):893-899. doi:10.1097/TA.0000000000001882</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0000000000001882</ArticleId><ArticleId IdType="pubmed">29521807</ArticleId></ArticleIdList></Reference><Reference><Citation>Linden A, Samuels SJ. Using balance statistics to determine the optimal number of controls in matching studies. J Eval Clin Pract. 2013;19(5):968-975. doi:10.1111/jep.12072</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jep.12072</ArticleId><ArticleId IdType="pubmed">23910956</ArticleId></ArticleIdList></Reference><Reference><Citation>Harder VS, Stuart EA, Anthony JC. Propensity score techniques and the assessment of measured covariate balance to test causal associations in psychological research. Psychol Methods. 2010;15(3):234-249. doi:10.1037/a0019623</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/a0019623</ArticleId><ArticleId IdType="pmc">PMC2936698</ArticleId><ArticleId IdType="pubmed">20822250</ArticleId></ArticleIdList></Reference><Reference><Citation>Trunkey DD. Trauma: accidental and intentional injuries account for more years of life lost in the US than cancer and heart disease: among the prescribed remedies are improved preventive efforts, speedier surgery and further research. Sci Am. 1983;249(2):28-35. doi:10.1038/scientificamerican0883-28</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/scientificamerican0883-28</ArticleId><ArticleId IdType="pubmed">6623052</ArticleId></ArticleIdList></Reference><Reference><Citation>Dowswell T, Towner EM, Simpson G, Jarvis SN. Preventing childhood unintentional injuries&#x2014;what works? a literature review. Inj Prev. 1996;2(2):140-149. doi:10.1136/ip.2.2.140</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ip.2.2.140</ArticleId><ArticleId IdType="pmc">PMC1067679</ArticleId><ArticleId IdType="pubmed">9346079</ArticleId></ArticleIdList></Reference><Reference><Citation>Holcomb JB, Fox EE, Zhang X, et al. ; PROMMTT Study Group . Cryoprecipitate use in the PROMMTT study. J Trauma Acute Care Surg. 2013;75(1)(suppl 1):S31-S39. doi:10.1097/TA.0b013e31828fa3ed</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0b013e31828fa3ed</ArticleId><ArticleId IdType="pmc">PMC3736696</ArticleId><ArticleId IdType="pubmed">23778509</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrison JJ, Ross JD, Dubose JJ, Jansen JO, Midwinter MJ, Rasmussen TE. Association of cryoprecipitate and tranexamic acid with improved survival following wartime injury: findings from the MATTERs II Study. JAMA Surg. 2013;148(3):218-225. doi:10.1001/jamasurg.2013.764</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamasurg.2013.764</ArticleId><ArticleId IdType="pubmed">23670117</ArticleId></ArticleIdList></Reference><Reference><Citation>Ditillo M, Hanna K, Castanon L, et al. . The role of cryoprecipitate in massively transfused patients: results from the Trauma Quality Improvement Program database may change your mind. J Trauma Acute Care Surg. 2020;89(2):336-343. doi:10.1097/TA.0000000000002764</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0000000000002764</ArticleId><ArticleId IdType="pubmed">32355101</ArticleId></ArticleIdList></Reference><Reference><Citation>Benjamin ER, Khor D, Cho J, Biswas S, Inaba K, Demetriades D. The age of undertriage: current trauma triage criteria underestimate the role of age and comorbidities in early mortality. J Emerg Med. 2018;55(2):278-287. doi:10.1016/j.jemermed.2018.02.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jemermed.2018.02.001</ArticleId><ArticleId IdType="pubmed">29685471</ArticleId></ArticleIdList></Reference><Reference><Citation>Mubang RN, Stoltzfus JC, Cohen MS, et al. . Comorbidity-polypharmacy score as predictor of outcomes in older trauma patients: a retrospective validation study. World J Surg. 2015;39(8):2068-2075. doi:10.1007/s00268-015-3041-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-015-3041-5</ArticleId><ArticleId IdType="pubmed">25809063</ArticleId></ArticleIdList></Reference><Reference><Citation>Lecky FE, Omar M, Bouamra O, et al. . The effect of preinjury warfarin use on mortality rates in trauma patients: a European multicentre study. Emerg Med J. 2015;32(12):916-920. doi:10.1136/emermed-2014-203959</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/emermed-2014-203959</ArticleId><ArticleId IdType="pubmed">25656561</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38079262</PMID><DateCompleted><Year>2024</Year><Month>03</Month><Day>29</Day></DateCompleted><DateRevised><Year>2025</Year><Month>08</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2163-0763</ISSN><JournalIssue CitedMedium="Internet"><Volume>96</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Apr</Month><Day>01</Day></PubDate></JournalIssue><Title>The journal of trauma and acute care surgery</Title><ISOAbbreviation>J Trauma Acute Care Surg</ISOAbbreviation></Journal><ArticleTitle>Endotheliopathy of trauma in children: The association of syndecan-1 with injury and poor outcomes.</ArticleTitle><Pagination><StartPage>566</StartPage><EndPage>572</EndPage><MedlinePgn>566-572</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/TA.0000000000004229</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The contribution of the endothelium to trauma-induced coagulopathy has not been thoroughly investigated in injured children.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This is a prospective cohort study of children (younger than 18 years) who presented with a potentially severe injury to an academic pediatric trauma center. Syndecan-1 level was collected on arrival and 24 hours following hospital arrival. Children were categorized as injured versus uninjured based on results of trauma evaluation. Demographics, injury characteristics, vital signs, and clinical laboratories were recorded. A composite clinical outcome was defined as death or blood product transfusion within 24 hours of hospital arrival. Statistical tests determined the impact of injury characteristics and therapeutics on syndecan-1 levels and assessed for associations between syndecan-1 level and outcomes.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 121 subjects were included in the analysis: 96 injured (79%) and 25 uninjured (21%). There were no differences between groups in age (median [interquartile range (IQR)], 11 [4-14] years), sex, or race. The injured cohort had a median (IQR) Injury Severity Score of 16 (9-21), 75% had blunt mechanism, 26% were transfused within 6 hours, 3% had 24-hour mortality, and 6% had in-hospital mortality. Median (IQR) syndecan-1 level on admission was significantly higher in injured versus uninjured cohort (44 [21-75] vs. 25 [17-42]; p = 0.04). Admission base deficit was significantly correlated with syndecan-1 level ( r = 0.8, p &lt; 0.001); no association with traumatic brain injury or injury mechanism was seen. Children with elevated syndecan-1 on admission had significantly increased odds of poor outcome; every 10 ng/mL increase in syndecan-1 was associated with 10% increased odds of death or transfusion ( p &lt; 0.001). Transfusion with any blood product was associated with a significant decrease in syndecan-1 from arrival to 24 hours (&#x394; syndecan-1, -17 [-64 to -5] vs. -8 [-19 to +2]; p &lt; 0001).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Elevated admission syndecan-1 level, suggestive of endotheliopathy, was associated with shock and poor outcomes in pediatric trauma. Larger cohort studies are required to fully describe the complexities of trauma-induced coagulopathy and investigate the benefit of therapies targeting endotheliopathy in children.</AbstractText><AbstractText Label="LEVEL OF EVIDENCE" NlmCategory="METHODS">Prognostic and Epidemiological; Level III.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 American Association for the Surgery of Trauma.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Morgan</LastName><ForeName>Katrina M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>From the Department of Surgery (K.M.M.), University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania; Department of Surgery (E.A.-K.), Northwestern University, Chicago, Illinois; Department of Surgery (B.A.G.), University of Texas Southwestern, Dallas, Texas; and Department of Surgery and Critical Care Medicine (C.M.L.), University of Pittsburgh Medical Center Pittsburgh, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abou-Khalil</LastName><ForeName>Elissa</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Gaines</LastName><ForeName>Barbara A</ForeName><Initials>BA</Initials></Author><Author ValidYN="Y"><LastName>Leeper</LastName><ForeName>Christine M</ForeName><Initials>CM</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Trauma Acute Care Surg</MedlineTA><NlmUniqueID>101570622</NlmUniqueID><ISSNLinking>2163-0755</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053668">Syndecan-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053668" MajorTopicYN="N">Syndecan-1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000070642" MajorTopicYN="Y">Brain Injuries, Traumatic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015601" MajorTopicYN="N">Injury Severity Score</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014947" MajorTopicYN="Y">Wounds and Injuries</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>29</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>11</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>11</Day><Hour>12</Hour><Minute>14</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38079262</ArticleId><ArticleId IdType="doi">10.1097/TA.0000000000004229</ArticleId><ArticleId IdType="pii">01586154-202404000-00006</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Web-based Injury Statistics Query and Reporting System (WISQARS) National Center for Injury Prevention and Control: Centers for Disease Control and Prevention. Available at: www.cdc.gov/ncipc/wisqars . Accessed January 8, 2024.</Citation></Reference><Reference><Citation>Lao Z, Gifford M, Dalal K. Economic cost of childhood unintentional injuries. Int J Prev Med . 2012;3(5):303&#x2013;312.</Citation></Reference><Reference><Citation>Cinat ME, Wallace WC, Nastanski F, West J, Sloan S, Ocariz J, et al. Improved survival following massive transfusion in patients who have undergone trauma. Arch Surg . 1999;134(9):964&#x2013;968 discussion 8-70.</Citation></Reference><Reference><Citation>Kauvar DS, Lefering R, Wade CE. Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations. J Trauma . 2006;60(6 Suppl):S3&#x2013;S11.</Citation></Reference><Reference><Citation>Cohen MJ, Kutcher M, Redick B, Nelson M, Call M, Knudson MM, et al. Clinical and mechanistic drivers of acute traumatic coagulopathy. J Trauma Acute Care Surg . 2013;75(1 Suppl 1):S40&#x2013;S47.</Citation></Reference><Reference><Citation>Brohi K, Singh J, Heron M, Coats T. Acute traumatic coagulopathy. J Trauma . 2003;54(6):1127&#x2013;1130.</Citation></Reference><Reference><Citation>Peltan ID, Vande Vusse LK, Maier RV, Watkins TR. An international normalized ratio-based definition of acute traumatic coagulopathy is associated with mortality, venous thromboembolism, and multiple organ failure after injury. Crit Care Med . 2015;43(7):1429&#x2013;1438.</Citation></Reference><Reference><Citation>Epstein DS, Mitra B, O'Reilly G, Rosenfeld JV, Cameron PA. Acute traumatic coagulopathy in the setting of isolated traumatic brain injury: a systematic review and meta-analysis. Injury . 2014;45(5):819&#x2013;824.</Citation></Reference><Reference><Citation>Maegele M, Schochl H, Cohen MJ. An update on the coagulopathy of trauma. Shock . 2014;41(Suppl 1):21&#x2013;25.</Citation></Reference><Reference><Citation>Whittaker B, Christiaans SC, Altice JL, Chen MK, Bartolucci AA, Morgan CJ, et al. Early coagulopathy is an independent predictor of mortality in children after severe trauma. Shock . 2013;39(5):421&#x2013;426.</Citation></Reference><Reference><Citation>Christiaans SC, Duhachek-Stapelman AL, Russell RT, Lisco SJ, Kerby JD, Pittet JF. Coagulopathy after severe pediatric trauma. Shock . 2014;41(6):476&#x2013;490.</Citation></Reference><Reference><Citation>Hendrickson JE, Shaz BH, Pereira G, Atkins E, Johnson KK, Bao G, et al. Coagulopathy is prevalent and associated with adverse outcomes in transfused pediatric trauma patients. J Pediatr . 2012;160(2):204&#x2013;9.e3.</Citation></Reference><Reference><Citation>Abou Khalil E, Gaines BA, Morgan KM, Leeper CM. Admission maximum amplitude-reaction time ratio: association between thromboelastography values predicts poor outcome in injured children. J Trauma Acute Care Surg . 2023;94(2):212&#x2013;219.</Citation></Reference><Reference><Citation>Hollingworth W, Vavilala MS, Jarvik JG, Chaudhry S, Johnston BD, Layman S, et al. The use of repeated head computed tomography in pediatric blunt head trauma: factors predicting new and worsening brain injury. Pediatr Crit Care Med . 2007;8(4):348&#x2013;356 CEU quiz 57.</Citation></Reference><Reference><Citation>Liras IN, Caplan HW, Stensballe J, Wade CE, Cox CS, Cotton BA. Prevalence and impact of admission acute traumatic coagulopathy on treatment intensity, resource use, and mortality: an evaluation of 956 severely injured children and adolescents. J Am Coll Surg . 2017;224:625&#x2013;632.</Citation></Reference><Reference><Citation>Leeper CM, Kutcher M, Nasr I, McKenna C, Billiar T, Neal MD, et al. Acute traumatic coagulopathy in a critically-injured pediatric population: definition, trend over time and outcomes. J Trauma Acute Care Surg . 2016;81:34&#x2013;41.</Citation></Reference><Reference><Citation>Leeper CM, Neal MD, McKenna C, Sperry JL, Gaines BA. Abnormalities in fibrinolysis at the time of admission are associated with deep vein thrombosis, mortality, and disability in a pediatric trauma population. J Trauma Acute Care Surg . 2017;82(1):27&#x2013;34.</Citation></Reference><Reference><Citation>Leeper CM, Neal MD, McKenna CJ, Gaines BA. Trending fibrinolytic dysregulation: fibrinolysis shutdown in the days after injury is associated with poor outcome in severely injured children. Ann Surg . 2017;266(3):508&#x2013;515.</Citation></Reference><Reference><Citation>Moore HB, Moore EE, Gonzalez E, Chapman MP, Chin TL, Silliman CC, et al. Hyperfibrinolysis, physiologic fibrinolysis, and fibrinolysis shutdown: the spectrum of postinjury fibrinolysis and relevance to antifibrinolytic therapy. J Trauma Acute Care Surg . 2014;77(6):811&#x2013;817; discussion 7.</Citation></Reference><Reference><Citation>Moore EE, Moore HB, Kornblith LZ, Neal MD, Hoffman M, Mutch NJ, et al. Trauma-induced coagulopathy. Nat Rev Dis Primers . 2021;7(1):30.</Citation></Reference><Reference><Citation>Nair AB, Schreiber MA, Pati S. Defining and assessing the endotheliopathy of trauma and its implications on trauma-induced coagulopathy and trauma-related outcomes. In: Moore HB, Neal MD, Moore EE, eds. Trauma Induced Coagulopathy . Cham: Springer International Publishing; 2021:117&#x2013;133.</Citation></Reference><Reference><Citation>Gonzalez Rodriguez E, Ostrowski SR, Cardenas JC, Baer LA, Tomasek JS, Henriksen HH, et al. Syndecan-1: a quantitative marker for the endotheliopathy of trauma. J Am Coll Surg . 2017;225(3):419&#x2013;427.</Citation></Reference><Reference><Citation>Johansson PI, Henriksen HH, Stensballe J, Gybel-Brask M, Cardenas JC, Baer LA, et al. Traumatic endotheliopathy: a prospective observational study of 424 severely injured patients. Ann Surg . 2017;265(3):597&#x2013;603.</Citation></Reference><Reference><Citation>Johansson PI, Stensballe J, Rasmussen LS, Ostrowski SR. A high admission syndecan-1 level, a marker of endothelial glycocalyx degradation, is associated with inflammation, protein C depletion, fibrinolysis, and increased mortality in trauma patients. Ann Surg . 2011;254(2):194&#x2013;200.</Citation></Reference><Reference><Citation>Jenkins DH, Rappold JF, Badloe JF, Bers&#xe9;us O, Blackbourne L, Brohi KH, et al. Trauma hemostasis and oxygenation research position paper on remote damage control resuscitation: definitions, current practice, and knowledge gaps. Shock . 2014;41(Suppl 1(0 1)):3&#x2013;12.</Citation></Reference><Reference><Citation>Wei S, Gonzalez Rodriguez E, Chang R, Holcomb JB, Kao LS, Wade CE. Elevated syndecan-1 after trauma and risk of sepsis: a secondary analysis of patients from the Pragmatic, Randomized Optimal Platelet and Plasma Ratios (PROPPR) trial. J Am Coll Surg . 2018;227(6):587&#x2013;595.</Citation></Reference><Reference><Citation>Rahbar E, Cardenas JC, Baimukanova G, Usadi B, Bruhn R, Pati S, et al. Endothelial glycocalyx shedding and vascular permeability in severely injured trauma patients. J Transl Med . 2015;13:117.</Citation></Reference><Reference><Citation>Sperry JL, Guyette FX, Brown JB, Yazer MH, Triulzi DJ, Early-Young BJ, et al. Prehospital plasma during air medical transport in trauma patients at risk for hemorrhagic shock. N Engl J Med . 2018;379(4):315&#x2013;326.</Citation></Reference><Reference><Citation>Nordin A, Coleman A, Shi J, Wheeler K, Xiang H, Acker S, et al. Validation of the age-adjusted shock index using pediatric trauma quality improvement program data. J Pediatr Surg . 2017.</Citation></Reference><Reference><Citation>Leonard JC, Josephson CD, Luther JF, Wisniewski SR, Allen C, Chiusolo F, et al. Life-threatening bleeding in children: a prospective observational study. Crit Care Med . 2021;49:1943&#x2013;1954.</Citation></Reference><Reference><Citation>Suzuki A, Tomita H, Okada H. Form follows function: the endothelial glycocalyx. Transl Res . 2022;247:158&#x2013;167.</Citation></Reference><Reference><Citation>Haywood-Watson RJ, Holcomb JB, Gonzalez EA, Peng Z, Pati S, Park PW, et al. Modulation of syndecan-1 shedding after hemorrhagic shock and resuscitation. PloS One . 2011;6(8):e23530.</Citation></Reference><Reference><Citation>Kozar RA, Pati S. Syndecan-1 restitution by plasma after hemorrhagic shock. J Trauma Acute Care Surg . 2015;78(6 Suppl 1):S83&#x2013;S86.</Citation></Reference><Reference><Citation>Pretorius D, Richter RP, Anand T, Cardenas JC, Richter JR. Alterations in heparan sulfate proteoglycan synthesis and sulfation and the impact on vascular endothelial function. Matrix Biology Plus . 2022;16:100121.</Citation></Reference><Reference><Citation>Gruen DS, Brown JB, Guyette FX, Johansson PI, Stensballe J, Li SR, et al. Prehospital tranexamic acid is associated with a dose-dependent decrease in syndecan-1 after trauma: a secondary analysis of a prospective randomized trial. J Trauma Acute Care Surg . 2023;95:642&#x2013;648.</Citation></Reference><Reference><Citation>Suzuki K, Okada H, Sumi K, Tomita H, Kobayashi R, Ishihara T, et al. Syndecan-1 as a severity biomarker for patients with trauma. Front Med (Lausanne) . 2022;9:985955.</Citation></Reference><Reference><Citation>Hatton GE, Isbell KD, Henriksen HH, Stensballe J, Brummerstedt M, Johansson PI, et al. Endothelial dysfunction is associated with increased incidence, worsened severity, and prolonged duration of acute kidney injury after severe trauma. Shock . 2021;55(3):311&#x2013;315.</Citation></Reference><Reference><Citation>Naumann DN, Hazeldine J, Davies DJ, Bishop J, Midwinter MJ, Belli A, et al. Endotheliopathy of trauma is an on-scene phenomenon, and is associated with multiple organ dysfunction syndrome: a prospective observational study. Shock . 2018;49(4):420&#x2013;428.</Citation></Reference><Reference><Citation>Ikeda M, Matsumoto H, Ogura H, Hirose T, Shimizu K, Yamamoto K, et al. Circulating syndecan-1 predicts the development of disseminated intravascular coagulation in patients with sepsis. J Crit Care . 2018;43:48&#x2013;53.</Citation></Reference><Reference><Citation>Russell RT, McDaniel JK, Cao W, Shroyer M, Wagener BM, Zheng XL, et al. Low plasma ADAMTS13 activity is associated with coagulopathy, endothelial cell damage and mortality after severe paediatric trauma. Thromb Haemost . 2018;118(4):676&#x2013;687.</Citation></Reference><Reference><Citation>Russell RT, Christiaans SC, Nice TR, Banks M, Mortellaro VE, Morgan C, et al. Histone-complexed DNA fragments levels are associated with coagulopathy, endothelial cell damage, and increased mortality after severe pediatric trauma. Shock . 2018;49(1):44&#x2013;52.</Citation></Reference><Reference><Citation>Richter RP, Russell RT, Hu PJ, Uhlich RM, Swain TA, Kerby JD, et al. Plasma Angiopoietin-2/&#x2212;1 ratio is elevated and Angiopoietin-2 levels correlate with plasma Syndecan-1 following pediatric trauma. Shock . 2019;52(3):340&#x2013;346.</Citation></Reference><Reference><Citation>Parimon T, Yao C, Habiel DM, Ge L, Bora SA, Brauer R, et al. Syndecan-1 promotes lung fibrosis by regulating epithelial reprogramming through extracellular vesicles. JCI Insight . 2019;5(17):e129359.</Citation></Reference><Reference><Citation>Bruegger D, Brettner F, Rossberg I, Nussbaum C, Kowalski C, Januszewska K, et al. Acute degradation of the endothelial glycocalyx in infants undergoing cardiac surgical procedures. Ann Thorac Surg . 2015;99(3):926&#x2013;931.</Citation></Reference><Reference><Citation>Oswald E, Stalzer B, Heitz E, Weiss M, Schmugge M, Strasak A, et al. Thromboelastometry (ROTEM&#xae;) in children: age-related reference ranges and correlations with standard coagulation tests. Br J Anaesth . 2010;105(6):827&#x2013;835.</Citation></Reference><Reference><Citation>Attard C, van der Straaten T, Karlaftis V, Monagle P, Ignjatovic V. Developmental hemostasis: age-specific differences in the levels of hemostatic proteins. J Thromb Haemost . 2013;11(10):1850&#x2013;1854.</Citation></Reference><Reference><Citation>Moynihan KM, Johnson K, Rane M, Norman A, Humphreys S, Stocker C, et al. Pediatric thromboelastograph 6s and laboratory coagulation reference values. Arch Pathol Lab . 2021;145(11):1413&#x2013;1423.</Citation></Reference><Reference><Citation>Hrebinko KA, Strotmeyer S, Richardson W, Gaines BA, Leeper CM. Sex dimorphisms in coagulation characteristics in the pediatric trauma population appear after puberty. J Trauma Acute Care Surg . 2022;92(4):675&#x2013;682.</Citation></Reference><Reference><Citation>Morgan KM, Abou-Khalil E, Strotmeyer S, Richardson WM, Gaines BA, Leeper CM. Age-related changes in thromboelastography profiles in injured children. J Trauma Acute Care Surg . 2023;95(6):905&#x2013;911.</Citation></Reference><Reference><Citation>Wataha K, Menge T, Deng X, Shah A, Bode A, Holcomb JB, et al. Spray-dried plasma and fresh frozen plasma modulate permeability and inflammation in vitro in vascular endothelial cells. Transfusion . 2013;53(Suppl 1):80s&#x2013;90s.</Citation></Reference><Reference><Citation>Kozar RA, Peng Z, Zhang R, Holcomb JB, Pati S, Park P, et al. Plasma restoration of endothelial glycocalyx in a rodent model of hemorrhagic shock. Anesth Analg . 2011;112(6):1289&#x2013;1295.</Citation></Reference><Reference><Citation>Peng Z, Pati S, Potter D, Brown R, Holcomb JB, Grill R, et al. Fresh frozen plasma lessens pulmonary endothelial inflammation and hyperpermeability after hemorrhagic shock and is associated with loss of syndecan 1. Shock . 2013;40(3):195&#x2013;202.</Citation></Reference><Reference><Citation>Diebel LN, Martin JV, Liberati DM. Early tranexamic acid administration ameliorates the endotheliopathy of trauma and shock in an in vitro model. J Trauma Acute Care Surg . 2017;82(6):1080&#x2013;1086.</Citation></Reference><Reference><Citation>Diebel ME, Martin JV, Liberati DM, Diebel LN. The temporal response and mechanism of action of tranexamic acid in endothelial glycocalyx degradation. J Trauma Acute Care Surg . 2018;84(1):75&#x2013;80.</Citation></Reference><Reference><Citation>Spinella PC, Leonard JC, Gaines BA, Luther JF, Wisniewski SR, Josephson CD, et al. Use of antifibrinolytics in pediatric life-threatening hemorrhage: a prospective observational multicenter study. Crit Care Med . 2022;50(4):e382&#x2013;e392.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40406232</PMID><DateCompleted><Year>2025</Year><Month>05</Month><Day>23</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>25</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2167-8359</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><PubDate><Year>2025</Year></PubDate></JournalIssue><Title>PeerJ</Title><ISOAbbreviation>PeerJ</ISOAbbreviation></Journal><ArticleTitle>Investigating the "off-hour effect" on outcomes of neonates undergoing emergency gastrointestinal surgery.</ArticleTitle><Pagination><StartPage>e19468</StartPage><MedlinePgn>e19468</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e19468</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7717/peerj.19468</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Evidence regarding the off-hour effect on outcomes in neonates with gastrointestinal disease who received urgent surgical intervention is unknown. Because of the workforce shortage, insufficient experience of surgeons, and delayed radiography examination during off-hours, we hypothesized that emergency surgeries performed during off-hours were associated with worse outcomes. This study aims to analyze the association between the "off-hour effect" and adverse events of neonates undergoing emergency gastrointestinal surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We extracted patient data from the electronic medical record system at our institution for all neonates undergoing emergency gastrointestinal surgery between July 2018 and October 2021. The primary outcomes were 24-hour and in-hospital mortality. The secondary outcomes were actual postoperative length of stay (PLOS) and the incidence of unplanned re-operation.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 275 neonates were identified, and 207 (75.3%) were treated during off-hours. The "off-hour effect" was not associated with increased 24-hour mortality, in-hospital mortality, PLOS, and unplanned re-operation. After propensity score matching, 68 off-hours were matched to the nearest 68 on-hours based on their age, weight, gestation weeks, and American Society of Anesthesiologists (ASA) status. No differences were detected in the primary and secondary outcomes.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">In this retrospective study with neonates who underwent emergency gastrointestinal surgery, after controlling for age, weight, gestation weeks, and ASA status, surgical and medical outcomes were not different in those undergoing off-hours surgery, which can be considered a surrogate for similar quality of care. However, in the future, a multi-center, prospective study is needed to confirm the results, to overcome the bias related to the presence of only one surgical team.</AbstractText><CopyrightInformation>&#xa9;2025 Cui.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The Affiliated Hospital, School of Medicine, UESTC Chengdu Women's &amp; Children's Central Hospital, Chengdu, Sichuan, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>05</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PeerJ</MedlineTA><NlmUniqueID>101603425</NlmUniqueID><ISSNLinking>2167-8359</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013505" MajorTopicYN="Y">Digestive System Surgical Procedures</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005767" MajorTopicYN="Y">Gastrointestinal Diseases</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004630" MajorTopicYN="N">Emergencies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012086" MajorTopicYN="N">Reoperation</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute abdomen</Keyword><Keyword MajorTopicYN="N">Gastrointestinal disease</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Neonates</Keyword><Keyword MajorTopicYN="N">Off-hour effect</Keyword></KeywordList><CoiStatement>The authors declare there are no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>12</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>4</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>5</Month><Day>23</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>5</Month><Day>23</Day><Hour>6</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>5</Month><Day>23</Day><Hour>4</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>5</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40406232</ArticleId><ArticleId IdType="pmc">PMC12097235</ArticleId><ArticleId IdType="doi">10.7717/peerj.19468</ArticleId><ArticleId IdType="pii">19468</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abdel-Latif ME, Bajuk B, Oei B, Lui K, New South Wales and the Australian Capital Territory Neonatal Intensive Care Audit&#xa0;Group Mortality and morbidities among very premature infants admitted after hours in an Australian neonatal intensive care unit network. Pediatrics. 2006;117:1632&#x2013;1639. doi: 10.1542/peds.2005-1421.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2005-1421</ArticleId><ArticleId IdType="pubmed">16651317</ArticleId></ArticleIdList></Reference><Reference><Citation>Akin MS, Cakir U. Evaluation of the relationship between day or night birth time and morbidities and mortality in premature infants less than 32 weeks in a Turkish NICU. Journal of Tropical Pediatrics. 2024;70:fmae049. doi: 10.1093/tropej/fmae049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/tropej/fmae049</ArticleId><ArticleId IdType="pubmed">39666940</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayar G, Yazici MU, Sahin S, Gunduz RC, Yakut HI, Akman AO, Kalkan G. Six year mortality profile of a pediatric intensive care unit: associaton between out-of-hours and mortality. Archivos Argentinos de Pediatria. 2019;117:120&#x2013;125. doi: 10.5546/aap.2019.eng.120.</Citation><ArticleIdList><ArticleId IdType="doi">10.5546/aap.2019.eng.120</ArticleId><ArticleId IdType="pubmed">30869485</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell CM, Redelmeier DA. Mortality among patients admitted to hospitals on weekends as compared with weekdays. New England Journal of Medicine. 2001;345:663&#x2013;668. doi: 10.1056/NEJMsa003376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMsa003376</ArticleId><ArticleId IdType="pubmed">11547721</ArticleId></ArticleIdList></Reference><Reference><Citation>Canal C, Lempert M, Birrer DL, Neuhaus V, Turina M. Short-term outcome after appendectomy is related to preoperative delay but not to the time of day of the procedure: a nationwide retrospective cohort study of 9,224 patients. International Journal of Surgery. 2020;76:16&#x2013;24. doi: 10.1016/j.ijsu.2020.02.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijsu.2020.02.001</ArticleId><ArticleId IdType="pubmed">32068181</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui Y, Cao R, Deng L. Inadvertent hypothermia and acute kidney injury (AKI) in neonates undergoing gastrointestinal surgeries: a retrospective study. Journal of Perinatology. 2022;42:247&#x2013;253. doi: 10.1038/s41372-021-01190-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41372-021-01190-8</ArticleId><ArticleId IdType="pubmed">34413460</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui Y, Cao R, Li J, Deng LM. Analysis of risk factors for unplanned reoperation following primary repair of gastrointestinal disorders in neonates. BMC Anesthesiology. 2021;21:128. doi: 10.1186/s12871-021-01345-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-021-01345-2</ArticleId><ArticleId IdType="pmc">PMC8063406</ArticleId><ArticleId IdType="pubmed">33892627</ArticleId></ArticleIdList></Reference><Reference><Citation>Da&#xa0;Silva PS, Reis ME, Fonseca TS, Fonseca MC. Do in-hours or off-hours matter for extubating children in the pediatric intensive care unit? Journal of Critical Care. 2016;36:97&#x2013;101. doi: 10.1016/j.jcrc.2016.06.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2016.06.028</ArticleId><ArticleId IdType="pubmed">27546755</ArticleId></ArticleIdList></Reference><Reference><Citation>Fonkalsrud EW, O&#x2019;Neill JA, Jabaji Z, Dunn JC. Changing relationship of pediatric surgical workforce to patient demographics. American Journal of Surgery. 2014;207:275&#x2013;280. doi: 10.1016/j.amjsurg.2013.07.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjsurg.2013.07.026</ArticleId><ArticleId IdType="pubmed">24246258</ArticleId></ArticleIdList></Reference><Reference><Citation>Grandhi R, Ravindra VM, Ney JP, Zaidat O, Taussky P, De&#xa0;Havenon A. Investigating the weekend effect on outcomes of patients undergoing endovascular mechanical thrombectomy for ischemic stroke. Journal of Stroke and Cerebrovascular Diseases. 2021;30:106013. doi: 10.1016/j.jstrokecerebrovasdis.2021.106013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jstrokecerebrovasdis.2021.106013</ArticleId><ArticleId IdType="pmc">PMC8511062</ArticleId><ArticleId IdType="pubmed">34375859</ArticleId></ArticleIdList></Reference><Reference><Citation>Kido T, Iwagami M, Abe T, Enomoto Y, Takada H, Tamiya N. Association between off-hour admission of critically ill children to intensive care units and mortality in a Japanese registry. Scientific Reports. 2021;11:14988. doi: 10.1038/s41598-021-94482-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-94482-0</ArticleId><ArticleId IdType="pmc">PMC8298565</ArticleId><ArticleId IdType="pubmed">34294821</ArticleId></ArticleIdList></Reference><Reference><Citation>Lillehei CW, Gauvreau K, Jenkins KJ. Risk adjustment for neonatal surgery: a method for comparison of in-hospital mortality. Pediatrics. 2012;130:e568-e74. doi: 10.1542/peds.2011-3647.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2011-3647</ArticleId><ArticleId IdType="pubmed">22926171</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelet D, Brasher C, Kaddour HB, Diallo T, Abdat R, Malbezin S, Bonnard A, Dahmani S. Postoperative complications following neonatal and infant surgery: common events and predictive factors. Anaesthesia Critical Care &amp; Pain Medicine. 2017;36:163&#x2013;169. doi: 10.1016/j.accpm.2016.05.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.accpm.2016.05.012</ArticleId><ArticleId IdType="pubmed">27671979</ArticleId></ArticleIdList></Reference><Reference><Citation>Purcell LN, Charles AG, Ricketts T, Akinkuotu A, McLean SE, Hayes-Jordan A, Phillips MR. The impact of general surgeons on pediatric surgical practice in North Carolina: the reality of pediatric surgical care delivery. Annals of Surgery. 2021;276(6):e976-e981. doi: 10.1097/SLA.0000000000005034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000005034</ArticleId><ArticleId IdType="pubmed">34183507</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravitch MM, Barton BA. The need for pediatric surgeons as determined by the volume of work and the mode of delivery of surgical care. Surgery. 1974;76:754&#x2013;763.</Citation><ArticleIdList><ArticleId IdType="pubmed">4422326</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocha G, Costa C, Correia-Pinto J, Monteiro J, Guimar&#xe3;es H. The acute abdomen in the newborn. Acta Medica Portuguesa. 2009;22:559&#x2013;566.</Citation><ArticleIdList><ArticleId IdType="pubmed">19944039</ArticleId></ArticleIdList></Reference><Reference><Citation>Toyokawa S, Hasegawa J, Ikenoue T, Asano Y, Jojima E, Satoh S, Ikeda T, Ichizuka K, Takeda S, Tamiya N, Nakai A, Fujimori K, Maeda T, Masuzaki H, Suzuki H, Ueda S. Weekend and off-hour effects on the incidence of cerebral palsy: contribution of consolidated perinatal care. Environmental Health and Preventive Medicine. 2020;25:52. doi: 10.1186/s12199-020-00889-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12199-020-00889-y</ArticleId><ArticleId IdType="pmc">PMC7488476</ArticleId><ArticleId IdType="pubmed">32912144</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang QQ, Xu J, Xiao X, Piao MH, Han TY. Association between time of birth and resuscitation outcomes in extremely preterm infants. Chinese Journal of Contemporary Pediatrics. 2021;23:702&#x2013;706. doi: 10.7499/j.issn.1008-8830.2104031.</Citation><ArticleIdList><ArticleId IdType="doi">10.7499/j.issn.1008-8830.2104031</ArticleId><ArticleId IdType="pmc">PMC8292653</ArticleId><ArticleId IdType="pubmed">34266527</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams V, Jaiswal N, Chauhan A, Pradhan P, Jayashree M, Singh M. Time of pediatric intensive care unit admission and mortality: a systematic review and meta-analysis. Journal of Pediatric Intensive Care. 2020;9(1):1&#x2013;11. doi: 10.1055/s-0039-3399581.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0039-3399581</ArticleId><ArticleId IdType="pmc">PMC6978166</ArticleId><ArticleId IdType="pubmed">31984150</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia XF, Chiu PWY, Tsoi KKF, Chan FKL, Sung JJY, Lau JYW. The effect of off-hours hospital admission on mortality and clinical outcomes for patients with upper gastrointestinal hemorrhage: a systematic review and meta-analysis of 20 cohorts. United European Gastroenterology Journal. 2018;6:367&#x2013;381. doi: 10.1177/2050640617732651.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2050640617732651</ArticleId><ArticleId IdType="pmc">PMC5949970</ArticleId><ArticleId IdType="pubmed">29774150</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang M, Ahn SY, Jo HS, Sung SI, Chang YS, Park WS, Korean Neonatal&#xa0;Network Mortality and morbidities according to time of birth in extremely low birth weight infants. Journal of Korean Medical Science. 2021;36(13):e86. doi: 10.3346/jkms.2021.36.e86.</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2021.36.e86</ArticleId><ArticleId IdType="pmc">PMC8021978</ArticleId><ArticleId IdType="pubmed">33821593</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Li W, Herath C, Xia J, Hu B, Song F, Cao S, Lu Z. Off-hour admission and mortality risk for 28 specific diseases: a systematic review and meta-analysis of 251 cohorts. Journal of the American Heart Association. 2016;5:e003102. doi: 10.1161/JAHA.115.003102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.115.003102</ArticleId><ArticleId IdType="pmc">PMC4943279</ArticleId><ArticleId IdType="pubmed">26994132</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29949624</PMID><DateCompleted><Year>2019</Year><Month>01</Month><Day>02</Day></DateCompleted><DateRevised><Year>2019</Year><Month>01</Month><Day>02</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>6</Issue><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Predicting mortality with the international classification of disease injury severity score using survival risk ratios derived from an Indian trauma population: A cohort study.</ArticleTitle><Pagination><StartPage>e0199754</StartPage><MedlinePgn>e0199754</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0199754</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0199754</ELocationID><Abstract><AbstractText Label="BACKGROUND">Trauma is predicted to become the third leading cause of death in India by 2020, which indicate the need for urgent action. Trauma scores such as the international classification of diseases injury severity score (ICISS) have been used with great success in trauma research and in quality programmes to improve trauma care. To this date no valid trauma score has been developed for the Indian population.</AbstractText><AbstractText Label="STUDY DESIGN">This retrospective cohort study used a dataset of 16047 trauma-patients from four public university hospitals in urban India, which was divided into derivation and validation subsets. All injuries in the dataset were assigned an international classification of disease (ICD) code. Survival Risk Ratios (SRRs), for mortality within 24 hours and 30 days were then calculated for each ICD-code and used to calculate the corresponding ICISS. Score performance was measured using discrimination by calculating the area under the receiver operating characteristics curve (AUROCC) and calibration by calculating the calibration slope and intercept to plot a calibration curve.</AbstractText><AbstractText Label="RESULTS">Predictions of 30-day mortality showed an AUROCC of 0.618, calibration slope of 0.269 and calibration intercept of 0.071. Estimates of 24-hour mortality consistently showed low AUROCCs and negative calibration slopes.</AbstractText><AbstractText Label="CONCLUSIONS">We attempted to derive and validate a version of the ICISS using SRRs calculated from an Indian population. However, the developed ICISS-scores overestimate mortality and implementing these scores in clinical or policy contexts is not recommended. This study, as well as previous reports, suggest that other scoring systems might be better suited for India and other Low- and middle-income countries until more data are available.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Attergrim</LastName><ForeName>Jonatan</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-9546-5788</Identifier><AffiliationInfo><Affiliation>Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sterner</LastName><ForeName>Mattias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Claeson</LastName><ForeName>Alice</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dharap</LastName><ForeName>Satish</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Lokmanya Tilak Municipal Medical College &amp; General Hospital, Mumbai, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gupta</LastName><ForeName>Amit</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Trauma Surgery &amp; Critical Care, J.P.N. Apex Trauma Center, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khajanchi</LastName><ForeName>Monty</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Seth GS Medical College and KEM Hospital, Mumbai, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Vineet</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Lokmanya Tilak Municipal Medical College &amp; General Hospital, Mumbai, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gerdin W&#xe4;rnberg</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>figshare</DataBankName><AccessionNumberList><AccessionNumber>10.6084/m9.figshare.5318218</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>06</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007194" MajorTopicYN="N" Type="Geographic">India</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015599" MajorTopicYN="Y">Trauma Severity Indices</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014947" MajorTopicYN="N">Wounds and Injuries</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Mr. Attergrim reports grants from Swedish National Board of Health and Welfare, grants from Swedish International Development Cooperation Agency, from Laerdal Foundation for Acute Medicine, during the conduct of the study. Dr. Gupta reports grants from Tata Institute of Social Sciences as Grants for manpower and contingencies for the collection of data from his Institution. Dr. Gerdin reports grants from Karolinska Institutet, during the conduct of the study.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>8</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>6</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>1</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>6</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29949624</ArticleId><ArticleId IdType="pmc">PMC6021077</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0199754</ArticleId><ArticleId IdType="pii">PONE-D-17-30424</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Vos T, Barber RM, Bell B, Bertozzi-Villa A, Biryukov S, Bolliger I, et al.
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990&#x2013;2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386: 743&#x2013;800. doi: 10.1016/S0140-6736(15)60692-4
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(15)60692-4</ArticleId><ArticleId IdType="pmc">PMC4561509</ArticleId><ArticleId IdType="pubmed">26063472</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandran A, Hyder AA, Peek-Asa C. The global burden of unintentional injuries and an agenda for progress. Epidemiol Rev. 2010;32: 110&#x2013;20. doi: 10.1093/epirev/mxq009
</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/epirev/mxq009</ArticleId><ArticleId IdType="pmc">PMC2912603</ArticleId><ArticleId IdType="pubmed">20570956</ArticleId></ArticleIdList></Reference><Reference><Citation>Mock C, Joshipura M, Arreola-Risa C, Quansah R. An estimate of the Number of Lives that Could be Saved through Improvements in Trauma Care Globally. World J Surg. 2012;36: 959&#x2013;963. doi: 10.1007/s00268-012-1459-6
</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-012-1459-6</ArticleId><ArticleId IdType="pubmed">22419411</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshipura MK. Trauma care in India: current scenario. World J Surg. 2008;32: 1613&#x2013;7. doi: 10.1007/s00268-008-9634-5
</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-008-9634-5</ArticleId><ArticleId IdType="pubmed">18553048</ArticleId></ArticleIdList></Reference><Reference><Citation>Goyal A, Yusuf S. Burden of disease in the India, NCMH. Indian J Med Res. 2006;124: 235&#x2013;244. 2005</Citation><ArticleIdList><ArticleId IdType="pubmed">17085827</ArticleId></ArticleIdList></Reference><Reference><Citation>Who. Injuries and Violence: The Facts. Geneva, Switz WHO; 2010; 2&#x2013;18.</Citation></Reference><Reference><Citation>Baker SP, O&#x2019;Neill B, Haddon W, Long WB. The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. J Trauma. 1974;14: 187&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">4814394</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsiao M, Malhotra A, Thakur JS, Sheth JK, Nathens AB, Dhingra N, et al.
Road traffic injury mortality and its mechanisms in India: nationally representative mortality survey of 1.1 million homes. BMJ Open. 2013;3: e002621
doi: 10.1136/bmjopen-2013-002621
</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2013-002621</ArticleId><ArticleId IdType="pmc">PMC3753525</ArticleId><ArticleId IdType="pubmed">23959748</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutledge R. The goals, development, and use of trauma registries and trauma data sources in decision making in injury. Surg Clin North Am. 1995;75: 305&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">7900000</ArticleId></ArticleIdList></Reference><Reference><Citation>Newgard CD, Fildes JJ, Wu L, Hemmila MR, Burd RS, Neal M, et al.
Methodology and analytic rationale for the American College of Surgeons Trauma Quality Improvement Program. J Am Coll Surg. 2013;216: 147&#x2013;57. doi: 10.1016/j.jamcollsurg.2012.08.017
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamcollsurg.2012.08.017</ArticleId><ArticleId IdType="pubmed">23062519</ArticleId></ArticleIdList></Reference><Reference><Citation>Krumholz HM. Mathematical Models and the Assessment of Performance in Cardiology. Circulation. 1999;99: 2067&#x2013;2069. doi: 10.1161/01.CIR.99.16.2067
</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.99.16.2067</ArticleId><ArticleId IdType="pubmed">10217642</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutledge R, Osler T, Emery S, Kromhout-Schiro S. The end of the Injury Severity Score (ISS) and the Trauma and Injury Severity Score (TRISS): ICISS, an International Classification of Diseases, ninth revision-based prediction tool, outperforms both ISS and TRISS as predictors of trauma patient survival,. J Trauma. 1998;44: 41&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">9464748</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutledge T, Deis R, Bedrick JRN. ICISS: An International Classification of Disease&#x2014;9 Based Injury Severity Score. 2016;41: 1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">8810953</ArticleId></ArticleIdList></Reference><Reference><Citation>Glance LG, Osler T. Beyond the major trauma outcome study: benchmarking performance using a national contemporary, population-based trauma registry. J Trauma. 2001;51: 725&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">11586166</ArticleId></ArticleIdList></Reference><Reference><Citation>Laytin AD, Kumar V, Juillard CJ, Sarang B, Lashoher A, Roy N, et al.
Choice of injury scoring system in low- and middle-income countries: Lessons from Mumbai. Injury. Elsevier Ltd; 2015;46: 2491&#x2013;2497. doi: 10.1016/j.injury.2015.06.029
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2015.06.029</ArticleId><ArticleId IdType="pubmed">26233630</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy N, Gerdin M, Schneider E, Kizhakke Veetil DK, Khajanchi M, Kumar V, et al.
Validation of international trauma scoring systems in urban trauma centres in India. Injury. 2016;47: 2459&#x2013;2464. doi: 10.1016/j.injury.2016.09.027
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2016.09.027</ArticleId><ArticleId IdType="pubmed">27667119</ArticleId></ArticleIdList></Reference><Reference><Citation>Meredith JW, Evans G, Kilgo PD, MacKenzie E, Osler T, McGwin G, et al. A comparison of the abilities of nine scoring algorithms in predicting mortality. J Trauma. 2002;53: 621-8-9.</Citation><ArticleIdList><ArticleId IdType="pubmed">12394857</ArticleId></ArticleIdList></Reference><Reference><Citation>Gagn&#xe9; M, Moore L, Beaudoin C, Batomen Kuimi BL, Sirois M-J. Performance of ICD-based injury severity measures used to predict in-hospital mortality: a systematic review and meta-analysis. J Trauma Acute Care Surg. 2015; doi: 10.1097/TA.0000000000000944
</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0000000000000944</ArticleId><ArticleId IdType="pubmed">26713976</ArticleId></ArticleIdList></Reference><Reference><Citation>Vergouwe Y, Steyerberg EW, Eijkemans MJC, Habbema JDF. Substantial effective sample sizes were required for external validation studies of predictive logistic regression models. 2005;58: 475&#x2013;483. doi: 10.1016/j.jclinepi.2004.06.017
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2004.06.017</ArticleId><ArticleId IdType="pubmed">15845334</ArticleId></ArticleIdList></Reference><Reference><Citation>Steyerberg EW, Borsboom GJJM, Van Houwelingen HC. Validation and updating of predictive logistic regression models: a study on sample size and shrinkage. 2004;2586: 2567&#x2013;2586. doi: 10.1002/sim.1844
</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.1844</ArticleId><ArticleId IdType="pubmed">15287085</ArticleId></ArticleIdList></Reference><Reference><Citation>R Core Team. R. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2015.</Citation></Reference><Reference><Citation>Margolis DJ, Bilker W, Boston R, Localio R, Berlin JA. Statistical characteristics of area under the receiver operating characteristic curve for a simple prognostic model using traditional and bootstrapped approaches. 2002;55: 518&#x2013;524.</Citation><ArticleIdList><ArticleId IdType="pubmed">12007556</ArticleId></ArticleIdList></Reference><Reference><Citation>Meredith JW, Kilgo PD, Osler TM. Independently derived survival risk ratios yield better estimates of survival than traditional survival risk ratios when using the ICISS. J Trauma. 2003;55: 933&#x2013;8. doi: 10.1097/01.TA.0000085646.71451.5F
</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.TA.0000085646.71451.5F</ArticleId><ArticleId IdType="pubmed">14608168</ArticleId></ArticleIdList></Reference><Reference><Citation>Kilgo PD, Osler TM, Meredith W. The worst injury predicts mortality outcome the best: rethinking the role of multiple injuries in trauma outcome scoring. J Trauma. 2003;55: 599&#x2013;606&#x2013;7. doi: 10.1097/01.TA.0000085721.47738.BD
</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.TA.0000085721.47738.BD</ArticleId><ArticleId IdType="pubmed">14566109</ArticleId></ArticleIdList></Reference><Reference><Citation>Gagn&#xe9; M, Moore L, Sirois M-J, Simard M, Beaudoin C, Kuimi BLB. Performance of International Classification of Diseases&#x2013;based injury severity measures used to predict in-hospital mortality and intensive care admission among traumatic brain-injured patients. J Trauma Acute Care Surg. 2017;82: 374&#x2013;382. doi: 10.1097/TA.0000000000001319
</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0000000000001319</ArticleId><ArticleId IdType="pubmed">28107311</ArticleId></ArticleIdList></Reference><Reference><Citation>Laytin AD, Dicker RA, Gerdin M, Roy N, Sarang B, Kumar V, et al.
Comparing traditional and novel injury scoring systems in a US level-I trauma center: an opportunity for improved injury surveillance in low- and middle-income countries. J Surg Res. 2017;215: 60&#x2013;66. doi: 10.1016/j.jss.2017.03.032
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jss.2017.03.032</ArticleId><ArticleId IdType="pubmed">28688663</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson S, Henley G, Harrison JE, Langley JD. Diagnosis based injury severity scaling: investigation of a method using Australian and New Zealand hospitalisations. Inj Prev. 2004;10: 379&#x2013;83. doi: 10.1136/ip.2004.005561
</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ip.2004.005561</ArticleId><ArticleId IdType="pmc">PMC1730146</ArticleId><ArticleId IdType="pubmed">15583261</ArticleId></ArticleIdList></Reference><Reference><Citation>Gedeborg R, Warner M, Chen L-H, Gulliver P, Cryer C, Robitaille Y, et al.
Internationally comparable diagnosis-specific survival probabilities for calculation of the ICD-10-based Injury Severity Score. J Trauma Acute Care Surg. 2014;76: 358&#x2013;65. doi: 10.1097/TA.0b013e3182a9cd31
</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0b013e3182a9cd31</ArticleId><ArticleId IdType="pubmed">24398769</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28611888</PMID><DateCompleted><Year>2018</Year><Month>03</Month><Day>06</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1936-9018</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>4</Issue><PubDate><Year>2017</Year><Month>Jun</Month></PubDate></JournalIssue><Title>The western journal of emergency medicine</Title><ISOAbbreviation>West J Emerg Med</ISOAbbreviation></Journal><ArticleTitle>Efficacy and Safety of Tranexamic Acid in Prehospital Traumatic Hemorrhagic Shock: Outcomes of the Cal-PAT Study.</ArticleTitle><Pagination><StartPage>673</StartPage><EndPage>683</EndPage><MedlinePgn>673-683</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.5811/westjem.2017.2.32044</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">The California Prehospital Antifibrinolytic Therapy (Cal-PAT) study seeks to assess the safety and impact on patient mortality of tranexamic acid (TXA) administration in cases of trauma-induced hemorrhagic shock. The current study further aimed to assess the feasibility of prehospital TXA administration by paramedics within the framework of North American emergency medicine standards and protocols.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This is an ongoing multi-centered, prospective, observational cohort study with a retrospective chart-review comparison. Trauma patients identified in the prehospital setting with signs of hemorrhagic shock by first responders were administered one gram of TXA followed by an optional second one-gram dose upon arrival to the hospital, if the patient still met inclusion criteria. Patients administered TXA make up the prehospital intervention group. Control group patients met the same inclusion criteria as TXA candidates and were matched with the prehospital intervention patients based on mechanism of injury, injury severity score, and age. The primary outcomes were mortality, measured at 24 hours, 48 hours, and 28 days. Secondary outcomes measured included the total blood products transfused and any known adverse events associated with TXA administration.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We included 128 patients in the prehospital intervention group and 125 in the control group. Although not statistically significant, the prehospital intervention group trended toward a lower 24-hour mortality rate (3.9% vs 7.2% for intervention and control, respectively, p=0.25), 48-hour mortality rate (6.3% vs 7.2% for intervention and control, respectively, p=0.76), and 28-day mortality rate (6.3% vs 10.4% for intervention and control, respectively, p=0.23). There was no significant difference observed in known adverse events associated with TXA administration in the prehospital intervention group and control group. A reduction in total blood product usage was observed following the administration of TXA (control: 6.95 units; intervention: 4.09 units; p=0.01).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Preliminary evidence from the Cal-PAT study suggests that TXA administration may be safe in the prehospital setting with no significant change in adverse events observed and an associated decreased use of blood products in cases of trauma-induced hemorrhagic shock. Given the current sample size, a statistically significant decrease in mortality was not observed. Additionally, this study demonstrates that it may be feasible for paramedics to identify and safely administer TXA in the prehospital setting.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Neeki</LastName><ForeName>Michael M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Arrowhead Regional Medical Center, Department of Emergency Medicine, Colton, California.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>California University of Sciences and Medicine, Colton, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Fanglong</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Western University of Health Sciences, College of Osteopathic Medicine of the Pacific, Pomona, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toy</LastName><ForeName>Jake</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Western University of Health Sciences, College of Osteopathic Medicine of the Pacific, Pomona, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vaezazizi</LastName><ForeName>Reza</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Inland Counties Emergency Medical Agency, San Bernardino, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Powell</LastName><ForeName>Joe</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>City of Rialto Fire Department, Rialto, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jabourian</LastName><ForeName>Nina</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Arrowhead Regional Medical Center, Department of Emergency Medicine, Colton, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jabourian</LastName><ForeName>Alex</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Arrowhead Regional Medical Center, Department of Emergency Medicine, Colton, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Arrowhead Regional Medical Center, Department of General Surgery, Colton, California.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>California University of Sciences and Medicine, Colton, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vara</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Arrowhead Regional Medical Center, Department of General Surgery, Colton, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seiler</LastName><ForeName>Kathryn</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Arrowhead Regional Medical Center, Department of Emergency Medicine, Colton, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pennington</LastName><ForeName>Troy W</ForeName><Initials>TW</Initials><AffiliationInfo><Affiliation>Arrowhead Regional Medical Center, Department of Emergency Medicine, Colton, California.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>California University of Sciences and Medicine, Colton, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Powell</LastName><ForeName>Joe</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>City of Rialto Fire Department, Rialto, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoshida-McMath</LastName><ForeName>Chris</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Inland Counties Emergency Medical Agency, San Bernardino, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kissel</LastName><ForeName>Shanna</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Riverside County Emergency Services Agency, Riverside, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schulz-Costello</LastName><ForeName>Katharine</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Arrowhead Regional Medical Center, Department of General Surgery, Colton, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mistry</LastName><ForeName>Jamish</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Arrowhead Regional Medical Center, Department of Emergency Medicine, Colton, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Surrusco</LastName><ForeName>Matthew S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Loma Linda University Medical Center, Department of General Surgery, Loma Linda, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Bosky</LastName><ForeName>Karen R</ForeName><Initials>KR</Initials><AffiliationInfo><Affiliation>Loma Linda University Medical Center, Department of General Surgery, Loma Linda, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Stralen</LastName><ForeName>Daved</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Loma Linda University Children's Hospital, Department of Pediatrics, Loma Linda, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ludi</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Riverside County Emergency Services Agency, Riverside, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sporer</LastName><ForeName>Karl</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Alameda County EMS Agency, San Leandro, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benson</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Riverside County Emergency Services Agency, Riverside, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwong</LastName><ForeName>Eugene</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Arrowhead Regional Medical Center, Department of Emergency Medicine, Colton, California.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>California University of Sciences and Medicine, Colton, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pitts</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Arrowhead Regional Medical Center, Department of Emergency Medicine, Colton, California.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>California University of Sciences and Medicine, Colton, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Culhane</LastName><ForeName>John T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>Arrowhead Regional Medical Center, Department of General Surgery, Colton, California.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>California University of Sciences and Medicine, Colton, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borger</LastName><ForeName>Rodney</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Arrowhead Regional Medical Center, Department of Emergency Medicine, Colton, California.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>California University of Sciences and Medicine, Colton, California.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>04</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>West J Emerg Med</MedlineTA><NlmUniqueID>101476450</NlmUniqueID><ISSNLinking>1936-900X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000933">Antifibrinolytic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>6T84R30KC1</RegistryNumber><NameOfSubstance UI="D014148">Tranexamic Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000933" MajorTopicYN="N">Antifibrinolytic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002140" MajorTopicYN="N">California</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004632" MajorTopicYN="N">Emergency Medical Services</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005240" MajorTopicYN="N">Feasibility Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006470" MajorTopicYN="N">Hemorrhage</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012771" MajorTopicYN="N">Shock, Hemorrhagic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014148" MajorTopicYN="N">Tranexamic Acid</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014947" MajorTopicYN="N">Wounds and Injuries</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Conflicts of Interest: By the WestJEM article submission agreement, all authors are required to disclose all affiliations, funding sources and financial or management relationships that could be perceived as potential sources of bias. No author has professional or financial relationships with any companies that are relevant to this study. There are no conflicts of interest or sources of funding to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>9</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>2</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>2</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>6</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>6</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>6</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28611888</ArticleId><ArticleId IdType="pmc">PMC5468073</ArticleId><ArticleId IdType="doi">10.5811/westjem.2017.2.32044</ArticleId><ArticleId IdType="pii">wjem-18-673</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Injury and Violence, The Facts - 2014. Geneva, Switzerland: World Health Organization; 2014.</Citation></Reference><Reference><Citation>WISQARS - Leading Causes of Death Reports, National and Regional, 1999&#x2013;2014. Centers for Disease Control and Prevention; 2015.  [Accessed Feb 23, 2016].  Available at:  http://www.cdc.gov/injury/wisqars/</Citation></Reference><Reference><Citation>Data &amp; Statistics (WISQARS&#x2122;): Cost of Injury Reports. Centers for Disease Control and Prevention; 2014. [Accessed Feb 23, 2016].</Citation></Reference><Reference><Citation>Brohi K, Singh J, Heron M, et al. Acute traumatic coagulopathy. J Trauma. 2003;54(6):1127&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">12813333</ArticleId></ArticleIdList></Reference><Reference><Citation>Niles SE, McLaughlin DF, Perkins JG, et al. Increased mortality associated with the early coagulopathy of trauma in combat casualties. J Trauma. 2008;64(6):1459&#x2013;63. 1463&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">18545109</ArticleId></ArticleIdList></Reference><Reference><Citation>Kauvar D, Lefering R, Wade C. Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations. J Trauma. 2006;60(6 Suppl):S3&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">16763478</ArticleId></ArticleIdList></Reference><Reference><Citation>Sauaia A, Moore F, Moore E, et al. Epidemiology of trauma deaths: a reassessment. J Trauma. 1995;38(2):185&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">7869433</ArticleId></ArticleIdList></Reference><Reference><Citation>Paudyal P, Smith J, Robinson M, et al. Tranexamic acid in major trauma: implementation and evaluation across South West England. Eur J Emerg Med. 2017;24(1):44&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">26313316</ArticleId></ArticleIdList></Reference><Reference><Citation>MacLeod JB, Lynn M, McKenney MG, et al. Early coagulopathy predicts mortality in trauma. J Trauma. 2003;55(1):39&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">12855879</ArticleId></ArticleIdList></Reference><Reference><Citation>Shackford SR, Mackersie RC, Holbrook TL, et al. The epidemiology of traumatic death. A population-based analysis. Arch Surg. 1993;128(5):571&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">8489391</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown JB, Neal MD, Guyette FX, et al. Design of the Study of Tranexamic Acid during Air Medical Prehospital Transport (STAAMP) Trial: addressing the knowledge gaps. Prehosp Emerg Care. 2015;19(1):79&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4623322</ArticleId><ArticleId IdType="pubmed">25076119</ArticleId></ArticleIdList></Reference><Reference><Citation>Shakur H, Roberts I, Bautista R, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010;376(9734):23&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">20554319</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts I, Shakur H, Afolabi A, et al. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet. 2011;377(9771):1096&#x2013;101.1101.e1&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">21439633</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts I, Shakur H, Coats T, et al. The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients. Health Technol Assess. 2013;17(10):1&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4780956</ArticleId><ArticleId IdType="pubmed">23477634</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrison J, Dubose J, Rasmussen T, et al. Military Application of Tranexamic Acid in Trauma Emergency Resuscitation (MATTERs) Study. Arch Surg. 2012;147(2):113&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">22006852</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipsky AM, Abracmovich A, Nadler R, et al. Transexamic acid in the prehospital setting: Israel Defense Forces&#x2019; initial experience. Injury. 2014;45(1):66&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">24074828</ArticleId></ArticleIdList></Reference><Reference><Citation>Vu EN, Schlamp RS, Wand RT, et al. Prehospital use of transexamic acid for hemorrhagic shock in primary and secondary air medical evacuation. Air Med J. 2013;32(5):289&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">24001917</ArticleId></ArticleIdList></Reference><Reference><Citation>Neeki MM, MacNeil C, Toy J, et al. Accuracy of perceived estimated travel time by EMS to a trauma center in San Bernardino County, California. West J Emerg Med. 2016;17(4):418&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4944798</ArticleId><ArticleId IdType="pubmed">27429692</ArticleId></ArticleIdList></Reference><Reference><Citation>Raza I, Davenport R, Rourke C, et al. The incidence and magnitude of fibrinolytic activation in trauma patients. J Thromb Haemost. 2013;11(2):307&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">23176206</ArticleId></ArticleIdList></Reference><Reference><Citation>Cap AP, Baer DG, Orman JA, et al. Tranexamic acid for trauma patients: a critical review of the literature. J Trauma. 2011;71(1 Suppl):S9&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">21795884</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawson JH, Murphy MP. Challenges for providing effective hemostasis in surgery and trauma. Semin Hematol. 2004;41(1 Suppl 1):55&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">14872423</ArticleId></ArticleIdList></Reference><Reference><Citation>Syrovets T, Lunov O, Simmet T. Plasmin as a proinflammatory cell activator. J Leukoc Biol. 2012;92(3):509&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">22561604</ArticleId></ArticleIdList></Reference><Reference><Citation>Jimenez JJ, Iribarren JL, Lorente L, et al. Tranexamic acid attenuates inflammatory response in cardiopulmonary bypass surgery through blockade of fibrinolysis: a case control study followed by a randomized double-blind controlled trial. Crit Care. 2007;11(6):R117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2246206</ArticleId><ArticleId IdType="pubmed">17988379</ArticleId></ArticleIdList></Reference><Reference><Citation>Toner RW, Pizzi L, Leas B, et al. Costs to hospitals of acquiring and processing blood in the US: a survey of hospital-based blood banks and transfusion services. Appl Health Econ Health Policy. 2011;9(1):29&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">21174480</ArticleId></ArticleIdList></Reference><Reference><Citation>Dowd NP, Karski JM, Cheng DC, et al. Pharmacokinetics of tranexamic acid during cardiopulmonary bypass. Anesthesiology. 2002;97(2):390&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">12151929</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigaut S, Tremey B, Ouattara A, et al. Comparison of two doses of tranexamic acid in adults undergoing cardiac surgery with cardiopulmonary bypass. Anesthesiology. 2014;120(3):590&#x2013;600.</Citation><ArticleIdList><ArticleId IdType="pubmed">23903022</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekback G, Axelsson K, Ryttberg L, et al. Tranexamic acid reduces blood loss in total hip replacement surgery. Anesth Analg. 2000;91(5):1124&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">11049894</ArticleId></ArticleIdList></Reference><Reference><Citation>Henry DA, Carless PA, Moxey AJ, et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev. 2011;1886;16(3):CD00.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiechtner BK, Nuttall GA, Johnson ME, et al. Plasma tranexamic acid concentrations during cardiopulmonary bypass. Anesth Analog. 2001;92(5):1131&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">11323334</ArticleId></ArticleIdList></Reference><Reference><Citation>Horrow JC, Van Riper DF, Strong MD, et al. The dose-response relationship of tranexamic acid. Anesthesiology. 1995;82(2):383&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">7856897</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilbrant A, Schannong M, Vessman J. Pharmacokinetics and bioavailability of tranexamic acid. Euro J Clin Pharmacol. 1981;20(1):65&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">7308275</ArticleId></ArticleIdList></Reference><Reference><Citation>O Eriksson H, Kjellman H, Pilbrant A. Pharmacokinetics of tranexamic acid after intravenous administration to normal volunteers. Euro J Clin Pharmacol. 1974;7(5):375&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">4422030</ArticleId></ArticleIdList></Reference><Reference><Citation>Benoni G, Bj&#xf6;rkman S, Fredin H. Application of pharmacokinetic data from healthy volunteers for the prediction of plasma concentrations of tranexamic Acid in surgical patients. Clin Drug Invest. 1995;10(5):280&#x2013;7.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">20622579</PMID><DateCompleted><Year>2010</Year><Month>08</Month><Day>03</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>18</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1529-8809</ISSN><JournalIssue CitedMedium="Internet"><Volume>69</Volume><Issue>1</Issue><PubDate><Year>2010</Year><Month>Jul</Month></PubDate></JournalIssue><Title>The Journal of trauma</Title><ISOAbbreviation>J Trauma</ISOAbbreviation></Journal><ArticleTitle>Prolonged prothrombin time after recombinant activated factor VII therapy in critically bleeding trauma patients is associated with adverse outcomes.</ArticleTitle><Pagination><StartPage>60</StartPage><EndPage>69</EndPage><MedlinePgn>60-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/TA.0b013e3181e17260</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">In trauma patients with significant hemorrhage, it is hypothesized that failure to normalize prothrombin time (PT) after recombinant activated factor VII (rFVIIa) treatment predicts poor clinical outcomes and potentially indicates a need for additional therapeutic interventions.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">To assess the value of PT to predict outcomes after rFVIIa or placebo therapy, we performed a post hoc analysis of data from 169 severely injured, critically bleeding trauma patients who had 1-hour postdose PT measurements from two randomized clinical trials. Baseline characteristics and outcome parameters were compared between subjects with 1-hour postdose PT &gt;or=18 seconds and PT &lt;18 seconds.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In rFVIIa-treated subjects, prolonged postdose PT values &gt;or=18 seconds were associated with significantly higher 24-hour mortality (60% vs. 3%; p &lt; 0.001) and 30-day mortality, increased incidence of massive transfusion, and fewer intensive care unit-free days compared with postdose PT values &lt;18 seconds. Recombinant rFVIIa-treated subjects with postdose PT &gt;or=18 seconds had significantly lower baseline hemoglobin levels, fibrinogen levels, and platelet counts than subjects with postdose PT values &lt;18 seconds even though they received similar amounts of blood products before rFVIIa dosing. Placebo-treated subjects with postdose PT &gt;or=18 seconds had significantly increased incidence of massive transfusion, significantly decreased intensive care unit-free days, and significantly lower levels of fibrinogen and platelets at baseline compared with subjects with postdose PT values &lt;18 seconds.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The presence of prolonged PT after rFVIIa or placebo therapy was associated with poor clinical outcomes. Because subjects with postdosing PT &gt;or=18 seconds had low levels of hemoglobin, fibrinogen, and platelets, this group may benefit from additional blood component therapy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>McMullin</LastName><ForeName>Neil R</ForeName><Initials>NR</Initials><AffiliationInfo><Affiliation>US Army Institute of Surgical Research, BAMC-Fort Sam Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wade</LastName><ForeName>Charles E</ForeName><Initials>CE</Initials></Author><Author ValidYN="Y"><LastName>Holcomb</LastName><ForeName>John B</ForeName><Initials>JB</Initials></Author><Author ValidYN="Y"><LastName>Nielsen</LastName><ForeName>Tina G</ForeName><Initials>TG</Initials></Author><Author ValidYN="Y"><LastName>Rossaint</LastName><ForeName>Rolf</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Riou</LastName><ForeName>Bruno</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Rizoli</LastName><ForeName>Sandro B</ForeName><Initials>SB</Initials></Author><Author ValidYN="Y"><LastName>Kluger</LastName><ForeName>Yoram</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Choong</LastName><ForeName>Philip I T</ForeName><Initials>PI</Initials></Author><Author ValidYN="Y"><LastName>Warren</LastName><ForeName>Brian</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Tortella</LastName><ForeName>Bartholomew J</ForeName><Initials>BJ</Initials></Author><Author ValidYN="Y"><LastName>Boffard</LastName><ForeName>Kenneth D</ForeName><Initials>KD</Initials></Author><Author ValidYN="Y"><CollectiveName>NovoSeven Trauma Study Group</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Trauma</MedlineTA><NlmUniqueID>0376373</NlmUniqueID><ISSNLinking>0022-5282</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006454">Hemoglobins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011994">Recombinant Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>9001-32-5</RegistryNumber><NameOfSubstance UI="D005340">Fibrinogen</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.21.21</RegistryNumber><NameOfSubstance UI="D015942">Factor VIIa</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015942" MajorTopicYN="N">Factor VIIa</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005340" MajorTopicYN="N">Fibrinogen</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006454" MajorTopicYN="N">Hemoglobins</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006470" MajorTopicYN="N">Hemorrhage</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010976" MajorTopicYN="N">Platelet Count</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011517" MajorTopicYN="Y">Prothrombin Time</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011994" MajorTopicYN="N">Recombinant Proteins</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014947" MajorTopicYN="N">Wounds and Injuries</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><InvestigatorList><Investigator ValidYN="Y"><LastName>Nicol</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tracey</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marx</LastName><ForeName>J S S</ForeName><Initials>JS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Degiannis</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Goosen</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Plani</LastName><ForeName>F</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fingleson</LastName><ForeName>L M</ForeName><Initials>LM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Payen</LastName><ForeName>J F</ForeName><Initials>JF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marty</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Krivosic-Horber</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Freysz</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>de La Coussaye</LastName><ForeName>J E</ForeName><Initials>JE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Duranteau</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Francois</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smail</LastName><ForeName>N</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Petit</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>van Aken</LastName><ForeName>H K</ForeName><Initials>HK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hempelmann</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rivkind</LastName><ForeName>A I</ForeName><Initials>AI</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shaked</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Michaelson</LastName></Investigator><Investigator ValidYN="Y"><LastName>Yan</LastName><ForeName>A Yeo Wan</ForeName><Initials>AY</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hameed</LastName><ForeName>S M</ForeName><Initials>SM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Samra</LastName><ForeName>G S</ForeName><Initials>GS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dobb</LastName><ForeName>G J</ForeName><Initials>GJ</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2010</Year><Month>7</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2010</Year><Month>7</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2010</Year><Month>8</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">20622579</ArticleId><ArticleId IdType="doi">10.1097/TA.0b013e3181e17260</ArticleId><ArticleId IdType="pii">00005373-201007000-00009</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>